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EXECUTIVE SUMMARY 
In September 2006 a Rapid Assessment and Response (RAR) addressing drug use and 
HIV/AIDS in Mongolia commissioned by the World Health Organisation Regional 
Office for the Western Pacific was conducted by a team from the Program of 
International Research and Training (PIRT) of the Australian National Drug and Alcohol 
Research Centre (NDARC). WHO RAR Guidelines were followed. Four members of 
PIRT spent a total of 59 person-days in country conducting research activities and 
writing this report. 
 
The HIV epidemic is still at a very early stage in Mongolia. However, Mongolia faces the 
threat of a future HIV epidemic and its potentially serious health, social and economic 
costs and risks to national security. Few HIV infections have been reported to date but 
the number of HIV infections is likely to far exceed the number of reported infections.  
 
Currently there is little injecting of illicit drugs in Mongolia and to date there have been 
no reported cases of HIV transmission occurring through injecting drug use. At present 
sexual transmission of HIV between clients and commercial sex workers (CSWs) and 
also among and from men who have sex with men (MSM) appear to be the most likely 
pathways that could result in HIV then spreading extensively to the general population 
during the next decade.  
 
Less critical risk groups and practices at the moment include: (i) heterosexual men and 
women, including especially mobile populations and migrant mining communities; (ii) 
medical injecting and skin penetration including in both the formal and informal 
(traditional) health care sectors and mainly involving patients prescribed morphine who 
inject themselves intra-venously frequently and for many years; and (iii) illicit injecting 
drug users. Street children (especially girls who may be at risk of becoming engaged in 
CSW) are also at risk. The high prevalence of hepatitis C, 16%-24% by some estimates, 
suggests that there is considerable use of used injecting and other skin penetration 
equipment in the health care and para-medical systems.  
 
Two of the five countries (China, Russia) in the world with the most rapidly increasing 
HIV epidemics are Mongolia‟s neighbours. This is of great concern. Unlike almost all 
other countries in Europe and Asia, there is little evidence so far of injecting drug use 
that has diffused through almost every other country in South East, South and East Asia 
in recent decades. Mongolia‟s isolation, accentuated by the harsh seasonal factors, sparse 
population, and current limited road, rail and air travel may have protected the country 
from the spread of injecting drug use till now. However, the high proportion of young 
people, high levels of youth unemployment, improving communications infrastructure 
and newly emerging pockets of affluence may herald rapidly increasing illicit drug use, 
including injecting drug use.  
 
In a number of countries, HIV has spread rapidly among and from injecting drug users 
in community and prison settings. In some of these countries, initial HIV spread among 
injecting drug users has precipitated generalised epidemics. Mongolia is currently ill-
prepared for this possibility.  
 
The Government of Mongolia appears to be well aware of the potential seriousness of 
the threat of HIV and has a high level commitment to keeping HIV under control. This 
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report recommends that the Government of Mongolia adopt a comprehensive approach 
to the threat of HIV/AIDS including:  
 Raising and maintaining high levels of awareness among the community of the 
risks of HIV;  
 Achieving improved results from the 100% condom utilisation programme in the 
commercial sex industry by implementing this programme throughout the 
country as rapidly as possible;  
 Strengthening STI policy and practice as a matter of urgency so that STIs in 
Mongolia are brought under control as soon as possible;  
 Promoting condom use in the general community;  
 Encouraging increased use of voluntary counselling and testing, especially among 
target groups including MSM, CSWs and emerging IDU populations;  
 Protecting the human rights and reducing the stigma experienced by target 
populations to facilitate more accessible and better services for these groups and 
reduce their engagement in HIV risk behaviours;  
 Reducing the re-use of un-sterile injecting equipment in the formal and informal 
health care systems;  
 Increasing the provision of non-judgemental, evidence based drug education in 
schools and in the community;  
 Increasing the capacity, expanding the range of options, and improving the 
quality of drug treatment by basing treatment on evidence and increasing 
funding;  
 
Many of the recommendations will benefit not only HIV prevention but will also assist in 
controlling STIs and reduce drug use.  
 
It is critical for Mongolia that the current low prevalence of HIV in the country is 
maintained as long as possible and that epidemic spread is averted. Early and vigorous 
action will avoid an HIV epidemic in Mongolia. As in other countries that have managed 
the HIV epidemic well, this will require strong political leadership and effective 
collaboration between health and justice ministries. The cost of action may seem rather 
high now but this will not compare with the much higher future cost of inaction.  
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BACKGROUND OF THIS ASSESSMENT 
In 2006 The World Health Organisation Western Pacific Regional Office commissioned 
a team from the Australian National Drug and Alcohol Research Centre (NDARC) to 
carry out a rapid assessment and response (RAR) addressing HIV/AIDS and illicit drug use 
particularly injecting drug use. 
 
An investigation of this nature was important at this time as there was some evidence to 
suggest that:  
 The prevalence of drug use and associated harms are increasing and unsafe 
injecting practices amongst IDUs occurs 
 While reported HIV/AIDS prevalence is low, actual infection rates may be 
higher than reported and are likely to be increasing 
 More people are engaging in commercial sex work and CSWs may be at risk of 
using drugs including injecting 
 Limited drug treatment services currently exist 
 Drug trafficking – a risk factor for drug use – is thought to occur through 
Mongolia but is poorly documented 
Aims and objectives 
The RAR was undertaken in order to strengthen the development of national strategies 
and responses to drug use and HIV/AIDS and to provide guidance to the Ministry of 
Health and World Health Organisation Country Office in Mongolia on how to support 
such activities. To date there has been a paucity of data to allow for informed and 
strategic planning of policy and interventions to address these issues.  
 
The study aimed to assess the following: 
 The nature and extent of drug use, especially injecting drug use and its impact in 
Mongolia 
 The current situation regarding HIV/AIDS in Mongolia, especially the risks of 
HIV transmission related to drug use  
 Interventions that exist to address HIV/AIDS and drug use 
  
Then, informed by these findings, the RAR team was to make recommendations on how 
to reduce the spread of HIV/AIDS in Mongolia.  
Agreement for performance of work1 
“ 1. Review of literature and existing data sources related to HIV/AIDS and 
drug use in Mongolia 
2. Conduct stakeholder analysis; interview stakeholders and other key 
informants including people who use drugs; conduct focus groups with key 
informants and members of the target population. 
3. Assess existing interventions and identify gaps in services 
                                                 
1
 World Health Organisation, Agreement for Performance of Work, Project: 
WP/2006/MOG/HIV/1.4/001 02.01.01.AW.01 
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4. Develop, in consultation with stakeholders, recommendations on the 
content of and how an effective response to drug use and HIV/AIDS can 
be developed in Mongolia. 
5. Conduct capacity building activities to enhance the ability of local 
organisations and staff to respond to issues relating to drug use and 
HIV/AIDS and contribute to the response. 
6. Provide recommendations specifically from the Ministry of Health on how 
they may address drug use issues and the prevention of HIV/AIDS.”1 
People involved  
The international study team was made up of the following members: Dr Alex Wodak2, 
Dr Anthony Shakeshaft3, Dr Effat Merghati Khoei3, and Dr Bradley Mathers3. Members 
of the study team undertook research activities in Mongolia from the 4th of September 
2006 involving a total of 59 person-days. A timetable of meetings, site visits and activities 
is included in Appendix I.  
 
The international study team was assisted by Dr Bavuu Enkhjin and Dr Khun 
Tsevegmidiin of the Ministry of Health and Dr Narantuya J. and Dr R. Jargalmaa from 
the World Health Organisation County Office in Mongolia. Research and translation 
assistance was also provided by Dr Elena Kazantseva and Dr Davaasuren Oyunsuren 
from the Centre of Mental Health and Narcology in Ulaanbaatar and Ms Pujeusuren 
Losol and Ms Buyanjargal, students from the Ulaanbaatar School of Public Health, Dr 
Delgermaa Enkhdalai from the Association to Protect the Population from Drugs and 
Opium and WHO volunteer Ms Natasha Pulaski from the United States of America. 
Scope and limitations of the RAR 
This RAR is an attempt to gain a picture of illicit drug use and the related issue of 
HIV/AIDS in Mongolia in order to provide sufficient information to be able to 
recommend appropriate responses to these issues of concern. It is not an attempt to 
precisely estimate the prevalence of either HIV or illicit drug use in Mongolia.   
 
The international team was able to spend only 59 person-days in Mongolia to conduct 
the research activities. No members of the team had any prior experience of Mongolian 
culture. None spoke Khalkha Mongol. Many key informants interviewed spoke limited 
English. The international researchers had to rely upon translators for communication in 
Mongolian and for assistance in reviewing documents not written in English.  
 
It had been anticipated that representatives from the Ministry of Health would be able to 
work closely with the international team. At the time of the assessment there were 
significant internal changes taking place at the Ministry of Health and it was not possible 
for the team to have a Ministry of Health counterpart for the duration of the mission. 
This created some logistical difficulties. Available Ministry of Health staff went out of 
their way to be very helpful to this project although the other considerable 
                                                 
2
 St Vincent’s Alcohol and Drug Service, Sydney, Australia 
 
3
 National Drug and Alcohol Research Centre, University of New South Wales, Sydney, Australia 
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responsibilities of these staff limited the amount of time they were able to assist the 
project.  
 
COUNTRY BACKGROUND  
Mongolia is approximately 1,564,116 square kilometres in size, situated between Russia 
to the north and China to the south. It has a mean elevation of 1500 metres above sea 
level (5000 ft) which contributes to its harsh continental climate. With an average annual 
temperature of -0.5º C, the capital city of Ulaanbaatar is the coldest capital city in the 
world. The large daily and seasonal temperature ranges are somewhat offset by more 
than 250 days of abundant sunshine.  
 
Mongolia is a country divided into 21 provinces or aimags, which are in turn divided into 
soums and further still into baghs. There are approximately 2,832,224 inhabitants with a 
population density of 1.4 persons per square kilometre. The average life expectancy is 64 
years. Almost one third (32.6%) of the total population is made up of persons aged less 
than 16years of age while 40% of the population comprises persons aged between 16-35 
years. The high literacy rate of 97.8% of the entire population is attributed to compulsory 
schooling between the ages of 8-16years. Despite this high rate of national literacy, 
unemployment remains at an obstinately high rate of 6.7%.  
 
The population comprises three nationalities; Khalkha Mongols form the majority with 
94%, Kazakhs account for 5%, and other nationalities such as Russian or Chinese make 
up the last 1%. More than 90% of the population speaks Mongolian, but many also speak 
Russian as a result of the occupation by the Soviet power until 1990. About half the 
population identifies itself as Tibetan Buddhist, with 6% classified as Shamanist or 
Christian sects, 4% Muslim, while 40% of the country does not officially practice any 
form of religion.  
 
Mongolia was occupied by the Soviet Union between 1924 and 1990, a situation which 
consequently saw it operating as a Communist state during this time. After the fall of the 
USSR and the departure of the Russians, the country has become a representative 
democratic republic. The governing parliament consists of two parties: the Mongolian 
People‟s Revolutionary Party (MPRP) and the Democratic Union Coalition (DUC). 
Executive power is held by the government whilst the legislature is controlled by both 
government and parliament. The judiciary is independent of both the legislature and 
executive branches. The parliament has 76 members, all elected for a four-year term by 
free and popular vote.  
 
The emphasis of the parliamentary outlook in recent years has seen the assumption of a 
human rights framework. The Mongolian constitution of 1992 ensured the “right of 
everyone to be recognized everywhere as a person before the law” and outlaws 
“discrimination of persons on the basis of ethnic origin, language, culture, race, age, sex, 
social origin or status, occupation or post, property, religion, opinion or education.” In 
this constitution Mongolia declares human rights in conformity with human rights 
instruments and establishes mechanisms to protect and promote human rights. Mongolia 
has ratified a number of core international treaties and conventions on human rights 
including the International Covenant on Civil and Political Rights, International 
Covenant on Social and Cultural Rights, Conventions on the Rights of Children, 
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Convention Against Torture and Other Cruel or Degrading Treatments and 
Punishments. 
 
Mongolia‟s economy is predominantly based on the raising of livestock and crop 
cultivation despite only 0.77% of its land being arable. The nation‟s agricultural industry 
overcomes this hurdle with livestock production mainly involving nomadic herding 
(sheep, goats, cows, horses, yaks and camels). The processing of the above products 
accounts for the bulk of goods manufactured nationally such as cashmere and varied 
food and beverage supplies. Alongside agriculture the mining industry is also a 
developing force, focusing at present on the extraction of coal, copper and gold amongst 
other minerals. Mining and quarrying grew by 34.4% in 2004.  
 
These industries have managed to sustain themselves through rapid government 
upheaval and change. Prior to 1990 about one third of the nation‟s GDP was supplied 
through Russian financial backing. After the Soviet departure from Mongolia, this capital 
assistance abruptly stopped. Following a decade of recession Mongolia‟s economy is 
beginning to recover, as demonstrated by a GDP (or purchasing power parity) of 
USD5.24 billion in 2005. The GDP per capita (or purchasing power parity) was 
estimated at USD 2,303 for men and USD 1,950 for women in 2003. The inflation rate 
in 2004 was 10.6%. The steady growth and improvement of the economy is generally 
attributed to a switch in economic strategies towards those of the free-market as well as 
privatization of Industry which was formerly state-owned.  
 
There are plans to establish free trading zone around Erlianhaut, on the Chinese side of 
the border and Zamiin-Uud, on the Mongolian side, which will certainly increase cross-
border movement and activity between the two countries.  
 
The means of transport within the country vary, but horseback still predominates in the 
countryside. The cities see more motorized transport, and the capital city uses a variety of 
cars, electric buses, and taxis. Domestic transport across the country is carried out by a 
combination of cart, motor vehicle or train. Internationally, the Trans-Siberian Railway 
carries passengers to and from Mongolia, as do regional flights on select airlines. 
However, the cost of travel is often a barrier to those in rural areas limiting their ability 
to receive basic and more advanced healthcare services. 
 
Indeed an inequity in basic services available to urban and rural populations exists within 
the country in general. A third (33 %) of the population lives without access to electricity 
while 82% of these people are identified as rural dwellers. In urban areas 62% of 
households have access to clean water and 46% to improved sanitation facilities. By 
contrast, only 45% of rural households have access to clean water and 28% to improved 
sanitation facilities. The Mongolian government is trying to improve the accessibility of 
these energy services to those living below the poverty line, 36.1% of the population.  
 
While the government hopes to see the use of modern energy sources benefiting the 
entire population, the production of such energy is problematic. Much of the power in 
Ulaanbaatar and throughout Mongolia is generated by the burning of coal. While coal is a 
cheaper form of energy than oil, the costs of burning the mineral on environmental and 
local health appears to override any immediate savings. In recent decades the air in the 
capital has become extremely polluted due to a lack of environmental regulations being 
enforced. This pollution in turn adversely affects the health of local residents, 
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contributing to high numbers of respiratory infections and exacerbating those already 
experiencing health problems. 
 
Income disparity between rural and urban areas as well as between males and females has 
increased. Women face a much greater incidence of poverty than men across the country. 
 
Mongolia has high maternal mortality, with 99 deaths per 100,000 live births in 2004. The 
infant mortality rate has declined from 64.4 per 1000 live births in 1990 to 48 per 1000 in 
1994 and stands at 22.8 per 1000 in 2005. The total fertility rate at present is 2.0 children. 
The health of the general Mongolian population is adversely affected by excessive 
malnutrition, which translates into numerous cases of rickets, anaemia, and iodine 
deficiency. Infectious diseases are also prevalent in the general populace, most notably 
STIs, viral hepatitis, and tuberculosis. The prominence of STIs is a source of concern for 
the future spread of HIV. Non-communicable diseases have also been on the rise. High 
rates of alcoholism and tobacco consumption have contributed to the growing numbers 
of cases of cancer, cardiovascular disease, injuries, and street deaths, such as traffic 
accidents and people freezing to death (commonly attributed to alcohol consumption). 
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METHODOLOGY 
Overview of the rapid assessment methodology 
This research activity was based upon the Rapid Assessment and Response methodology 
outlined in the WHO Rapid Assessment and Response Guide on Psychoactive Substance 
Use and Sexual Risk Behaviour, the WHO Response Guide on Injecting Drug Use and 
the WHO Rapid Assessment and Response Technical Guide.  
 
The rapid assessment methodology is a technique to gather information in a short period 
in order to inform the development of responses to a particular issue of concern. It has 
been used extensively in many settings to explore issues related to HIV/AIDS and drug 
use. The methods of information gathering are well recognised and used in many fields 
including applied anthropology, sociology and evaluative research. Various research tools 
are used and methodology aims to shorten the duration of the research process while 
providing comprehensive information about the subject. Existing data sources are 
explored; primary information is collected from different key players using a variety of 
different research tools. Both qualitative and quantitative methods are used. The process 
is based upon the principals of induction and triangulation. Tools are used only to 
explore the relevant information required to fill existing gaps in information.  
Location of assessment 
Approximately half of the Mongolian population lives in the capital city, Ulaanbaatar, 
and this is where existing evidence suggested most drug use occurs. Also, as the RAR 
team had only limited time to conduct the assessment, most research activities took place 
in Ulaanbaatar and focused on the situation in this city, judged to be the most important 
geographical location for this study.  
 
Members of the RAR team also travelled to the cities of Erdenet and Darkhan, the 
second and third largest urban centres respectively as well as Sukhbaatar, the city closest 
to Mongolia‟s northern border crossing with Russia (see Error! Reference source not 
found.). In each of these locations the RAR team members met key stakeholders and 
informants from relevant organisations and government departments, visited treatment 
and support services and, where possible, held focus groups and conducted interviews 
with members of the target groups. 
Review of literature, print media and existing material 
Existing literature and data sources were located and reviewed. Both published and 
unpublished material was examined.  
 
A search of the published medical literature was conducted using Medline. Other English 
language online material was searched using the <google.com> search engine 
 
Reports produced by government ministries, international non-government and UN 
organisations and local NGOs were requested and reviewed. Many of these reports were 
available only in the Mongolian language; these were translated into English. We were 
unable to review official material from the Ministry of Justice, as we were unsuccessful in 
obtaining the necessary permission to access this information.  
 
Media coverage of drug use and HIV/AIDS was reviewed. Local medical students were 
employed to review major Mongolian language print newspapers published in the last 12 
  15 
months and extract relevant articles. Online Mongolian language news coverage of drug 
use and HIV issues was searched using the <google.mn> search engine. 
Stakeholder analysis 
With the assistance of WHO Country Office staff relevant stakeholders were identified.  
These stakeholders were assessed as to their suitability to join the advisory group and/or 
act as key-informants.  
Convening of the Advisory Group 
A wide range of key stakeholders were invited to join the RAR advisory group. A list of 
these organisations and individuals is included in Appendix II. The group met four times 
during the course of the RAR. Not all of the invited stakeholders were able to attend all 
the meetings.  
 
It had been hoped that drug users would also participate in this group. Unfortunately 
those individuals invited to participate were not able to attend the meetings.  
 
In the first meeting, held on the 11th of September, the international study team briefed 
the group on the intended purpose, objectives and methods of the RAR. The group gave 
feedback and advice on how the assessment might be conducted and suggested 
informants who should be contacted, other sources of information and strategies to 
recruit injecting drug users.  
 
The group met again on the 25th of September and were briefed on the activities and 
findings of the assessment to date. The group provided feedback on these findings and 
recommended ways in which to overcome some of the challenges encountered, in 
particular the difficulties of recruiting injecting and other drug users.  
 
Two meetings were held during the international team‟s final week in country on the 4th 
and 6th of October. Group members discussed the final findings and analysis and 
suggested corrections to any errors of fact or omission. The recommendations were 
debated and revised. 
Site visits 
A range of government and non-government services were visited by members of the 
RAR team. The team also visited a number of nightclubs and entertainment venues 
where key informants identified drug use might occur. Sites visited are detailed in 
Appendix II. 
Meetings with key informants 
The study team met with a wide range of key informants. This included government and 
law enforcement officials, treatment and support service staff and outreach workers in 
Ulaanbaatar, Erdenet, Darkhan and Sukhbaatar. A list of key informants met is included 
in Appendix II. 
Recruitment of research assistants 
Medical students from the School of Medicine in Ulaanbaatar were recruited to conduct 
interviews and assist with the research activities of the rapid assessment. These students 
were paid for their time working on this assignment. Specific tasks involved helping 
design and translate a questionnaire for interviewing drug users, recruiting drug users for 
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interviews, conducting interviews; reviewing media reports on drug use and HIV/AIDS 
and acting as interpreters. 
Recruitment of injecting and other drug users 
The RAR team attempted to recruit injecting and other drug users by use of the snowball 
technique.  
 
The small number of injecting drug users that accessed treatment and support services 
were approached and invited to take part in the study and most were willing to 
participate. However, most were injectors of morphine that had previously been 
prescribed to them and as a result used drugs in isolation from other drug users and were 
unable to put the study team in contact with other potential participants. Drug use 
appears to occur primarily in private; there was no evidence of public injecting in 
Mongolia and as such drug users were not easily identified and accessed in public places 
 
Students from the Ulaanbaatar School of Medicine, working as research assistants in the 
RAR, made contact with other university students in Ulaanbaatar via the extensive 
network of student clubs and again by the snowball technique recruited drug users to 
participate in the study.   
 
A total of 23 injecting drug users and 20 non-injecting drug users were recruited and 
interviewed. 
Interviews with injecting and other drug users 
A structured questionnaire was developed exploring drug use history, drug using and 
sexual risk-behaviours, HIV knowledge and experience of treatment services. The 
questionnaire was piloted with three respondents, then revised and translated into 
Mongolian. The English version of the questionnaire is included in Appendix III. 
Information from completed questionnaires was entered into SPSS.  
Focus groups 
Focus group discussions were held with Chinese migrant labourers, men who have sex 
with men, university students and commercial sex workers. Unfortunately the team was 
unsuccessful at recruiting injecting and other drug users to participate in a focus group. 
Many reported they were unwilling to participate, as they were reluctant to disclose their 
drug use to others.  
Methodological constraints 
Most of the information obtained was gathered from interviews with key informants as 
only a small number of injecting and other drug users were accessed. The study team 
believe that this difficulty in accessing injecting drug users indicates that there are few 
injecting drug users in Mongolia and that this small population is very well hidden. These 
views are consistent with the consensus opinion of experienced local experts.  
Capacity building and training activities 
The international team members conducted a training session on drugs, harm reduction 
and drug treatment. The session was attended by workers from NGOs, the Ministry of 
Health and the Centre of Mental Health and Narcology.  
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Students from the School of Public Health, and staff from the Centre of Mental Health 
and Narcology and the Association for the Protection of the Population From Drugs 
and Opium worked alongside the international study team and assisted with the research 
activities. It was hoped that this participation would also enhance local capacity. 
 
One member of the RAR Team assisted a Ministry of Health representative and a 
medical doctor based at the first Maternity Hospital in Ulaanbaatar with the design of an 
evaluation strategy with which to assess the effectiveness of a brief intervention 
addressing alcohol use and pregnancy.  
 
During the RAR it became apparent that there was a lack of resources for a perceived 
increase of problematic cannabis use amongst young people. Consequently the RAR 
team arranged for a series of relevant resources from the National Drug and Alcohol 
Research Centre to be sent to the Ministry of Health and the MHNC for adaptation and 
use as appropriate.  
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FINDINGS 
Current national policy and strategies  
HIV/AIDS prevention strategy and policy  
Since 1987, the Mongolian government has developed a number of HIV/AIDS policies. 
A National AIDS Committee responsible for leadership and management of HIV/AIDS 
prevention and control has been disbanded. Currently a Public Health Committee 
chaired by the Prime Minister was established in 2002 and is responsible for coordinating 
public health programs including HIV/AIDS. The committee has representatives from 
the Mongolian Red Cross and the Trade Union of Health Professionals but does not 
have representatives from the private sector or civil society organisations working in the 
HIV/AIDS field or people living with HIV/AIDS. 
 
Legislation has been adopted to strengthen HIV/AIDS prevention and control and to 
address related human rights, equality and confidentiality issues. There had been 
incidents previously where confidentiality had been breached and the names of HIV 
positive people released publicly.  
 
The first National AIDS program approved by the National AIDS Committee was 
initiated for the period of 1992-2000. At the time of preparing this report, a draft 
National AIDS Strategy: Strategy to control HIV/AIDS/STI 2006 – 2010 was being 
considered by the Government. This draft strategy lists a number of priority areas 
including HIV/AIDS awareness and education activities, increasing condom usage, 
targeting of at risk groups, expanding VCT and HIV/AIDS treatment and care services 
and continued monitoring of HIV. There is little mention of measures relating to HIV 
transmission through injecting drug use. 
Legislation pertaining to illegal drugs 
The Law of Mongolia on Control of Trafficking in narcotic drugs and psychotropic 
substances, dated 28th of November 2002, defines the legitimate and illegitimate use of 
narcotic drugs in Mongolia as well as the restrictions on manufacture, importation and 
sale of these and other illicit substances. The RAR team understands that those found to 
have committed an offence under this law are not subject to „criminal‟ liability but may 
have an administrative penalty consisting of a fine ranging from MNT30,000 – 
MNT250,000 (approximately USD25.00 – USD215.00) imposed depending on the 
nature of the violation and whether the offender is a citizen, official or organisation.  
 
Under this law a person who has been assessed by a health institution to be addicted to a 
drug may be forced to undergo medical treatment.  
 
This law also states that the curriculum of secondary and high school classes must 
include information on the hazards of narcotic and psychotropic drug use and 
prevention of drug use. It also states that the mass media has an obligation to 
disseminate information on the hazards of drug use.  
 
Decree Number 306 by the Minister of Health, dated December 25th 2003, outlines the 
rules related to procurement, manufacture and use of narcotic drugs and psychotropic 
substances. Appendix IV of this decree lists narcotic drugs and substances that can be 
used for medical purposes in Mongolia. This list includes buprenorphine, methadone, 
oxycodone and oxymorphone, drugs that may have some place in the treatment to 
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opioid dependence. The RAR team understands that while drugs listed under this decree 
can be lawfully used for medical purposes in Mongolia, they are currently not available.  
National anti-drug program  
The Government of Mongolia had a National Program for Fighting Narcotics and Drugs 
for the period 2000-2005. At the time of preparing this report the 2006-2010 National 
Program has not yet been finalised. The National Council headed by the Chief of Police 
coordinated the implementation of the 2000-2005 program which aimed to prevent drug 
addiction, drug related crimes, create a legal basis for fighting drugs, implement counter 
narcotics policy, and raise public awareness of the issue of drug abuse. Under this 
program the Ministry of Justice, Ministry of Education, Ministry of Health, General 
Customs Department, the General Department of Police, Central Intelligence Agency, 
mass media, NGOs and City and Aimag Government Offices were all identified as 
having a responsibility to contribute to this process. The Program focused primarily on 
law enforcement and drug supply reduction and to a lesser extent on reducing the 
demand for drugs. It is likely that the 2006- 2010 National Program will be of a similar 
nature.   
International conventions and treaties 
Mongolia is a party to the 1988 UN Drug Convention, the 1961 Single Convention As 
Amended by its 1972 Protocol, and the 1971 UN Convention on Psychotropic 
Substances. Mongolia also has obligations under the UN General Assembly Resolution 
S-26/2 (Declaration of Commitment on HIV/AIDS from the United Nations General 
Assembly Special Session on HIV/AIDS). 
 
Mongolia became a member of the Asia Pacific Group on Money Laundering in 2004 
and has committed to adhere to Financial Action Taskforce (FATF) standards, while 
seeking participation and eventual membership in the FATF. 
 
HIV/AIDS in Mongolia 
Prevalence of HIV/AIDS:  
As in most other countries, it is generally considered that HIV infection in Mongolia is 
under-reported. The WHO and UNAIDS currently estimate that the number of HIV 
infected persons in Mongolia is fewer than 500 cases, rating it as „low level‟ epidemic 
(UNAIDS 2006).  
 
The print media has also covered the issue of HIV/AIDS. Estimates in the popular press 
of the number of HIV cases were as high as 2500. There appeared to be little coverage of 
the nature of the virus and how it is transmitted.  
 
As of the 31st of August 2006 there were 25 reported cases of HIV infection in Mongolia. 
Single new cases were reported in 1992, 1997, 2001, 2003 and 2004. In 2005 eleven new 
cases were reported and nine to date in 2006.  
 
Twenty three of these 25 people were resident in Ulaanbaatar at the time of diagnosis 
and two were from Huvsgul province in northern Mongolia.  
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Details of all 16 cases of HIV/AIDS officially reported up until the end of 2005 are 
presented in Table 1. 
 
Table 1: Reported cases of HIV/AIDS (UNAIDS 2006) 
Cases Reported 
Month & Year  
Route of infection and known risk factors Current status 
1 August 1992 Sexual. MSM, had lived abroad Died of AIDS 
1999 
2 December 1997 Sexual. CSW HIV+ve 
3 July 2001 Sexual. Female, cross border trader, had multiple 
partners 
Died of AIDS 
2001 
4 January 2003 Sexual. Female, had lived abroad Died of AIDS 
2005 
5 October 2004 Sexual. MSM HIV+ve 
6 March 2005 Sexual. Male, detected through screening of TB 
patients 
HIV+ve and 
TB 
7 April 2005 Sexual. MSM HIV+ve 
8 April 2005 Sexual. MSM HIV+ve 
9 April 2005 Unknown.  HIV+ve 
10 June 2005 Sexual. MSM HIV+ve 
11 July 2005 Sexual. Female, had lived abroad, detected through 
screening of pregnant women 
HIV+ve 
12 August 2005 Sexual MSM HIV+ve 
13 September 2005 Sexual MSM AIDS patient 
14 October 2005  Sexual. Male, had lived abroad HIV+ve 
15 November 2005 Sexual. Female had lived abroad HIV+ve 
16 November 2005 Sexual. MSM, detected through screening of TB 
patients 
HIV+ve and 
TB 
 
As of September 2006, four of the 25 people diagnosed with HIV in Mongolia have died. 
Currently one person has been diagnosed to have AIDS and is currently receiving anti-
retroviral (ARV) treatment at the National Centre for Communicable Diseases (NCCD). 
Demographic characteristics of HIV cases  
Eight of the people infected (32%) were female and 17 (68%) were male.  The majority 
were between 25 and 35 years of age at the time of diagnosis. The age at the time of 
diagnosis is given in Table 2. Marital status, employment and level of education are 
detailed in tables 3, 4 and 5 respectively.  
 
Table 2: Age at time of HIV diagnosis  
Age Number of cases 
20 – 24 years 1 
25 – 29 years 9 
30 – 34 years 7 
35 – 39 years 4 
40 – 44 years 4 
 
Table 3: Marital status at time of HIV diagnosis  
Marital status Number of cases 
Single 11 
Married 6 
De-facto relationship 2 
Divorced 5 
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Unknown 1 
 
Table 4: Employment at time of HIV diagnosis  
Occupation Number of cases 
Unemployed 14 
Employed 6 
Self-employed 2 
Student 3 
 
Table 5: Level of education of people diagnosed with HIV 
Highest level of 
education attained 
Number of cases 
1 – 4 Grade 5 
5 – 8 Grade 6 
9 – 10 Grade 7 
University 7 
HIV transmission 
All cases of HIV infection in Mongolia to date have been attributed to sexual 
transmission. Twelve cases have been attributed to sex between men and nine to 
heterosexual transmission. Transmission in an additional four cases has been attributed 
to commercial sex work – it is not clear from the information provided whether or not 
this involved heterosexual or male-to-male sex nor whether those infected were 
commercial sex workers or clients. It is more likely that these cases involved heterosexual 
contact.  
HIV and STI co-infection 
At the time of diagnosis, HIV positive individuals were also tested for sexually 
transmitted and other infections. The proportion with a combination of sexually 
transmitted infections and HIV is extremely high (see Table 6). 
 
Table 6: Incidence of other infection at time of diagnosis 
Other infection Number of 
cases 
Syphilis 10 
Gonorrhoea  1 
HPV 2 
HBV 4 
HCV 1 
TB 2 
HIV/AIDS education and knowledge 
The 2005 UNGASS Country Report for Mongolia (UNAIDS 2006) reported low levels 
of HIV knowledge among the general population. Three percent of males and 5% of 
females aged 15–24 were able to both correctly identify ways of preventing the sexual 
transmission of HIV and rejected major misconceptions about HIV transmission. Rural 
youths are considerably less knowledgeable than young people in urban centres.  
 
Among the sample of drug users that were interviewed during this RAR, all had heard of 
HIV/AIDS. Seventeen of the 23 IDUs interviewed considered themselves not to be at 
risk of contracting HIV. Nineteen of 23 IDUs and 10 of 20 other drug users had been 
tested for HIV.  
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It has been estimated that 68.1% of MSM and 58% of CSWs were reached by HIV 
prevention programs such as community outreach programs that include peer education; 
exposure to targeted mass media; sexually transmitted infection screening and/or 
treatment (UNAIDS 2006). These figures are based on fairly low estimates of the size of 
the MSM and CSW populations and as such may overestimate the coverage of these 
programs. 
 
Again, it seems likely that these estimates are too high due to an underestimation of the 
total number of MSM and CSWs in Mongolia.  
HIV testing 
Government health centres and some private health care services conduct HIV testing. 
Health centres in all aimags are expected by the Government of Mongolia to have the 
capacity to test for HIV. In practice however, many health centres lack testing kits some 
or all of the time. Most HIV testing is funded by the Global Fund to Fight AIDS, 
Tuberculosis and Malaria (GFATM) as part of HIV surveillance activities (discussed 
below).  
 
Every year between 30 000 and 60 000 HIV tests are performed on high- and low-risk 
populations. A senior health official reported to this Mission that HIV testing is 
sometimes involuntary and that pre- and post-test counselling is not always adequate. 
The National AIDS Foundation (NAF) is attempting to improve these practices so to 
achieve acceptable standards of VCT. People in Mongolia who consider themselves to be 
at risk of HIV are able to request and usually obtain a free HIV test. All new cases of TB 
infection, STI patients, pregnant women and blood donors are routinely tested for HIV. 
Men who have sex with men (MSM) and CSWs are encouraged by NGOs who work 
with these groups to undergo testing for HIV. From 2005, mobile HIV testing has been 
conducted and proven to be a successful way of reaching a widely distributed population. 
This commonly involves organising a social event in an aimag capital where information 
on HIV/AIDS is provided and VCT is offered.  
 
In 2005 it was estimated that 67% of MSM and 23.2% of CSWs have had an HIV test in 
the previous 12 months and were advised of the results (UNGASS Report 2005). Again 
it is possible that these estimates may be somewhat high due to underestimation of the 
total number of MSM and CSW in Mongolia.  
HIV surveillance 
The Ministry of Health and the GFATM conducts second-generation surveillance (SGS) 
of HIV/AIDS. Fifty percent of the reported cases of HIV in Mongolia were detected by 
this surveillance activity. To date surveillance has included the investigation of the 
following sentinel groups:  
 Male STI clients – men, aged 24 – 29 years, who attended public STI clinics 
selected as sentinel sites during the sample period 
 Mobile men – men, aged 24 – 49 years, who have been away from their home 
communities for more than one month in the last 12 months for employment 
(mobile traders, informal miners, and truck drivers) 
 Men who have sex with men (MSM) – Men aged 24 – 49 years, who have had 
anal sex with men in the last twelve months 
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 Female sex workers – Females who received money for sex services in the last 
twelve months 
 Youth – young unmarried people of both sexes enrolled in secondary or higher 
education institutions and aged 15 – 24 years. 
 Pregnant women – women attending antenatal care for the first visit during the 
year of study 
 Blood donors – people donating blood at selected health facilities during the year 
of study 
 TB patients – patients diagnosed with TB for the first time during the year of 
study 
The inclusion of IDUs as a separate sentinel group in this surveillance has been 
considered. Those responsible for this surveillance considered that because the number 
of IDUs in Mongolia is so small, including this population would add little value and 
their recruitment would be very difficult. The RAR team concurred with this judgement.  
 
In the 2005 round of SGS, participants were asked whether or not they had ever used, or 
specifically, whether they had ever injected drugs. The findings are discussed below in the 
section on drug use.  
Government response to HIV/AIDS 
The national policy relating to HIV/AIDS in Mongolia is discussed in the „HIV/AIDS 
Prevention Strategy and Policy‟ section of this document. 
 
In 2005, the Government of Mongolia spent an estimated US$ 172 867 from domestic 
funds on responses to HIV (UNAIDS 2006). Considerable funding for activities 
addressing HIV/AIDS is provided from international donor sources including from the 
Global Fund to Fight AIDS, Tuberculosis and Malaria. 
Non-government sector response to HIV/AIDS 
The National AIDS Foundation (NAF) was established in 2000. It receives funds from 
the Alliance, the GFATM and other UN agencies. The NAF is the peak HIV/AIDS 
non-government organisation in Mongolia. It acts as a link agency for international HIV 
surveillance and prevention activities, provides technical, organisational and financial 
support to various community based organisations and advocates on behalf of people at 
risk of HIV and people living with HIV/AIDS. 
 
Currently the NAF works in collaboration with a number of organisations including the 
APPDO, Together Centre, Association of Public Health Professionals, Association 
Against Alcoholism and Drug Abuse and a community based organisation targeting 
CSWs. 
 
Drug use in Mongolia 
The use of illicit as well as diverted controlled drugs does occur in Mongolia. However 
by far the most commonly used drugs are the legal substances alcohol and tobacco. This 
is consistent with other countries in the region and developed countries and is a 
reflection of the cultural acceptance, relative affordability and wide availability of these 
legal drugs. 
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Prevalence of illicit drug use in Mongolia 
A small number of studies have been conducted in the last seven years to determine the 
nature and extent of illegal drug use in Mongolia.  
 
Since 1999, the Association for the Protection of the Population from Drugs and Opium 
has conducted a number of surveys of high school and university students and other 
young people in Ulaanbaatar, Erdenet, Sukhbaatar and Darkhan. Few details of the 
methodology and only very general descriptive results from these investigations were 
available. Some key informants highlighted the methodological limitations of these 
studies. The key findings from these surveys are outlined below: 
 
In 1999, 1000 young people, aged between 13 and 25 years were interviewed. 
Forty five reported ever having used a drug, 28 had used a drug only once, 13 had 
used occasionally and four reported using drugs regularly. The types of drugs used 
and the route by which they were taken were not specified. 
 
In 2000, 1000 young people aged between 13 and 25 years were interviewed.  
Fifty two reported ever having used a drug, 28 had used a drug only once, 18 had 
used occasionally and six used drugs regularly. 
The types of drugs used were not specified but 22 reported smoking drugs, eight 
sniffing, 20 drinking and two injecting.  
 
In 2002, 1000 young people aged between 14 and 18 years of age were interviewed. 
Thirty reported ever having used a drug, 16 had used a drug only once, seven had 
used occasionally and seven used drugs regularly. Again the types of drugs used 
were not specified but 19 reported smoking drugs, five sniffing and six drinking 
while none reported injecting a drug.  
 
In 2003, 1500 people were interviewed. Forty five people reported ever having 
used a drug, 32 had used a drug only once, 13 had used occasionally and 15 used 
drugs regularly. Thirty nine reported having smoked a drug, 16 had taken a drug by 
sniffing and 27 had injected a drug.  
The most commonly injected drug was morphine. The injection of fentanyl and 
pentazocine, a partial opioid agonist, was also reported.  
 
In 2004, 840 people were interviewed. Sixty reported ever having used a drug, 32 
had used a drug only once, 13 had used occasionally and 15 used drugs regularly. 
The types of drugs used were not specified but 19 reported smoking drugs, five 
sniffing, six drinking, none had injected a drug.  
 
These studies were conducted with limited resources. Due to the methodological 
limitations of these studies it is not possible to determine any significant trends over 
time.  
 
The most extensive recent assessment of psychoactive drug use in Mongolia was 
conducted in 2001 by the National Aids Foundation of Mongolia (National AIDS 
Foundation 2001). This Participatory Situation Assessment examining HIV and drug use 
found evidence of only limited illicit drug use in Mongolia. Drug use was found to occur 
mainly in Ulaanbaatar with cannabis, morphine and diazepam being the most commonly 
reported drugs. Only limited injecting drug use was found.  
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Medical treatment and other service providers reported having little contact with drug 
users. Accordingly there is little clinical experience of treating patients with injecting and 
other illicit drug using issues.  
 
In 2005, a total number of 43 officially diagnosed and registered cases of psychoactive 
drug use related disorders, excluding alcohol and tobacco, were recorded from all 
government medical facilities in Mongolia. These results are displayed in Table 7.  
 
Table 7: Officially diagnosed and registered cases of substance use related disorders in Mongolia in 2005, 
excluding alcohol and tobacco. 
ICD – 10 classification Number of cases 
F11 Mental and behavioural disorders due to use of 
opioids 
9 
F12 Mental and behavioural disorders due to use of 
cannabinoids 
1 
F13 Mental and behavioural disorders due to use of 
sedatives or hypnotics 
24 
F18 Mental and behavioural disorders due to use of 
volatile solvents 
9 
 
Currently the Centre of Mental Health and Narcology in Ulaanbaatar have only four 
registered patients who are illicit drug users. All four are morphine injectors and all four 
began using morphine for the treatment of chronic pain following trauma or surgery.  
 
The National Anti-Drug Centre has in the past offered support services to a very small 
number of injecting morphine users and cannabis users. Currently a larger number of 
young solvent users are receiving assistance from the organisation.   
 
The Association Against Alcoholism and Drug Abuse has to date only had experience 
dealing with users of alcohol and has had very little contact with other drug users. 
 
The Association for the Protection of the Population Against Drugs and Opium 
reported that between six and 18 IDUs attend the service every week to obtain sterile 
injecting equipment and other services.  
 
Media reports reviewed suggest that illicit drug use is increasing in Mongolia. There are 
varied reports of drug dealers, with police reporting at least one apprehended dealer. 
Such cases reported in the popular press suggest that users come from wealthy families in 
Mongolia. The drug use referred to seems confined to non-injectable drugs and in 
particular cannabis.  
 
There appears to be a growing sense of public concern that the Mongolian population is 
increasingly vulnerable to drugs. Many newspaper articles provided information to 
increase parental awareness of their children‟s use and experimentation with narcotics, 
alcohol and tobacco products. Many articles highlight the negative aspects of different 
drugs and to promote an understanding of their potential harm in an effort to encourage 
people to learn how to say „No‟ to offers of drugs. One article went even further 
suggesting that the country should be rid itself of drug addicts entirely.  
Socio-demographic characteristics of drug users 
Key informants believed that most drug users were either injectors of pharmaceutical 
morphine who began using the drug after having been prescribed it for chronic non-
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malignant pain and most are over thirty years of age or were aged between 17 and 30 
years of age and users of other drugs, particularly cannabis. It was felt by many that illicit 
drugs were expensive and at that only those with disposable incomes such as young 
people from wealthy families were likely to be able to afford them. 
 
Six of the 22 IDUs interviewed and only one of the 13 non-injecting drug users 
interviewed were female. Age distribution of the two groups is detailed in Table 8. 
 
Table 8: Age distribution of interviewed IDU and non-injecting drug users 
Age (years) Number of IDUs Number of Non-IDUs 
≤20 2 1 
21-25 6 11 
26-30 3 0 
31-35 1 1 
36-40 1 0 
41-45 3 0 
46-50 1 0 
51-55 5 0 
 
Among the IDUs, eight were married or in a de-facto relationship, seven were divorced 
and six had never married. Fourteen had no religion, seven identified as Buddhist and 
one as Christian. 
 
Fourteen IDUs had attended university and the remaining eight had received at least 
eight years of schooling. All but one of the non-injecting drug users interviewed had 
attended university, which was unsurprising as most were recruited via tertiary student 
networks.  
 
Of the IDUs interviewed, daily income ranged from MNT1000 (USD0.85) to 
MNT100,000 (USD85.00). 
 
Thirteen out of 14 non-injecting drug users lived in an apartment and one in a “small 
house”. Around half of the IDUs lived in apartments or “large” houses, and half in 
“small houses”. Small houses referred to include gers (felt tents) and other small shelters 
or shacks.  
Drug related forensic and mortality data 
In an effort to find evidence of injecting and other illicit drug use the RAR team 
reviewed forensic and mortality data that might indicate a cause of death attributable to 
drug use.  
 
According to records provided by the Department of Forensic Medicine National Centre 
of Forensic Investigation between 2000 and 2005, 11.7% of all deaths investigated by the 
department were attributed to poisoning. Of these, alcohol was responsible for 72.3% of 
cases, medications for 5.8%. Of poisoning from medications 86.1% were due to 
diphenhydramine hydrochloride (Dimedrol), 9% form the tricyclic antidepressant 
amitriptyline and 4.5% due to acetyl-salicylic acid (aspirin). The age breakdown of these 
deaths attributed to poisoning from medications is detailed in Table 9. 
 
Table 9: Age breakdown of deaths attributed to poisoning from medications  
Age (years) Percentage 
10-19 36.3% 
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20-29 40.9% 
30-39 18.1% 
≥40 4.7% 
 
Of the deaths due to “alcohol poisoning” 87.2% were male and 12.8% female. 57.5% of 
these deaths occurred at home. The age breakdown of these deaths attributed to alcohol 
poisoning is detailed in Table 10.  
 
Table 10: Age breakdown of deaths attributed to poisoning from alcohol  
Age (years) Percentage 
10-19 2.2% 
20-29 13.4% 
30-39 31.7% 
40-49 34.3% 
50-59 11.9% 
60-75 6.3% 
 
The remaining poisoning deaths were due to carbon monoxide inhalation and other 
poisonous chemicals such as fertilisers. 
 
No deaths were recorded as having resulted from poisoning by illicit drugs.  
 
In Ulaanbaatar all acute poisoning cases are referred to the Poisoning Hospital. Clinicians 
at the hospital reported that they treat very few opiate overdoses - only one such case 
occurred in the last two years. Admissions for drug poisoning between 2003 and 2005 
are detailed in Table 11. 
 
Table 11: Admissions to the Ulaanbaatar Poisoning Hospital for drug poisoning, 2003-2005 
Drug 2003 2004 2005 
Dimedrol 86 70 42 
Benzodiazepines 25 26 23 
Mixed 57 63 45 
Other 120 112 128 
Unknown 9 4 - 
Alcohol 46 42 56 
 
„Street death‟ is a common phenomenon in urban centres in Mongolia. A large 
proportion involve a person being found frozen in the street. Most street deaths involve 
men. Between 2000 and 2004 alcohol was a contributing factor in 60% of all street 
deaths. A common scenario involves an intoxicated person becoming unconscious in the 
street and then dying of exposure. A similar chain of events might well involve 
intoxication by other substances. In the data available there were no street deaths 
recorded where any other drugs were found to be a contributing factor.  
Pharmaceutical opiates 
Medical use and regulation of pharmaceutical opiates 
Mongolia is currently licensed under International Narcotics Control Board (INCB) 
regulations to import 10kg of opiates but currently imports well under this amount. 
Official figures from the Ministry of Health, Pharmaceuticals and Medical Devices 
Department show that in 2004, Mongolia imported the equivalent of 1080g of codeine, 
1380g of morphine and 8.96g of fentanyl.  
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Morphine and fentanyl are used in hospitals in Mongolia for the treatment of severe 
acute and chronic pain following a major surgical procedure, serious injury or pain 
associated with malignancy.  
 
The National Trauma Hospital in Ulaanbaatar uses more opiates for the treatment of 
non-malignant pain than any other facility in Mongolia. In 2004, the hospital used 1,300 
ampoules of morphine and 1,470 ampoules of fentanyl. Clinicians reported that 
morphine and fentanyl are used only in cases of very severe pain and normally no more 
than 4-5 patients out of a total of 420 inpatients are prescribed morphine at any time. 
Hospital clinicians and administrators reported that they did not believe there was much 
chance of diversion of opiates from the hospital as all opiates are administered to 
inpatients under strictly supervised conditions.  In 2006, doctors at the hospital became 
able to prescribe oral tramadol for the management of pain following a patient‟s 
discharge from the hospital. It is only in very rare instances that a patient will be 
prescribed injectable morphine as an out-patient. 
 
Several regulations control the dispensing of opiates from community pharmacies. City 
and regional health departments are responsible for the licensing of pharmacies 
permitted to dispense morphine. There are over 300 pharmacies in Ulaanbaatar. In rural 
areas each soum, and in urban areas each district, may have only one, and in some cases 
two, pharmacies permitted to dispense morphine.  
 
The National Provisional Inspection Agency is responsible for the monitoring of listed 
narcotic and psychotropic drugs dispensed by pharmacies and hospitals in Mongolia. 
Inspectors review pharmacy records and monitor how drugs are supplied, stored and 
dispensed. Due to limited resources, only a limited number of pharmacies are inspected 
and reviewed each year. 
 
Representatives from the City Health Department in Ulaanbaatar and the National 
Provisional Inspection Agency reported that many pharmacies are reluctant to stock 
morphine as they fear either harassment from morphine users attempting to obtain 
morphine without prescription or having morphine stolen from their premises. Both 
representatives felt that pharmacies require greater security protection to protect against 
these threats. 
 
The City Health Department representative believed that regulations and monitoring of 
pharmacies is good but suspected that around 10% of pharmacies might dispense 
medications inappropriately such as giving drugs to family members without a 
prescription or dispensing more of a medication than the amount stated on a 
prescription. 
 
Some key informants also believed that it is possible to obtain medications including 
morphine without prescription from some pharmacies. Some also reported that 
morphine is sold illegally on the black market.  
 
Of 22 morphine injectors interviewed, five reported obtaining morphine on prescription 
from a pharmacy or dispensed from a hospital. Nine reported acquiring pharmaceutical 
morphine from pharmacies without prescription. Six reported buying morphine from a 
drug dealer and five from the black market.  
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Non medical use of pharmaceutical opiates 
Among the limited numbers of injecting drug users who attend treatment services and 
support organisations, almost all are morphine injectors. Service providers report that 
most of these injecting drug users have a history of major surgery or trauma resulting in 
chronic pain for which they were prescribed injectable morphine. These patients then go 
on to develop a dependence on morphine, using the drug in increasing  doses and 
frequency, continuing to obtain the medication on prescription from pharmacies and 
supplementing this supply by other means. 
 
Of the 22 IDU interviewed, 16 had used morphine regularly in the last three months. 
Ten reported also injecting other pharmaceuticals, including diazepam (Seduxen) and 
diphenhydramine hydrochloride (Dimedrol). Others reported occasionally using fentanyl 
but this appeared to be harder to obtain.  
 
The use of injectable morphine with no history of prior medical use is less common. 
These individuals appear more likely to be primarily injecting drug users and consumers 
of other psychoactive substances such as cannabis.  
 
Staff form the Narcology Hospital in Ulaanbaatar reported that in the last five years only 
five patients have been admitted for morphine dependence. These patients are often 
brought to the hospital, against their wishes, by police. In most cases the patients self 
discharge after twenty four hours before treatment can be completed. The current 
treatment protocol for morphine dependence involves supportive care and morphine 
administered in a reduction regime dependent upon the patient‟s level of drug use.  
 
The Centre of Mental Health and Narcology provide out-patient treatment. To date it 
has also treated very few illicit drug dependent patients. In September 2006 the centre 
was seeing four drug dependent patients – all morphine injectors who had been 
previously prescribed the drug. The centre offers counselling and social support for these 
patients. The staff at the centre identified their limited experience and capacity to treat 
illicit drug dependent patients. Staff from the centre also believed that many drug users 
might be reluctant to seek help at the centre as it is a Ministry of Health facility and they 
fear that because it is a government institution they may be in danger of being turned 
over to the police.  
 
The APPDO has offered drug dependence recovery programs involving a course based 
on the twelve step Narcotics Anonymous model for opioid dependent people. 
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CASE HISTORY:  
B, 35 year old female 
B began using morphine for the treatment of chronic pain following an 
injury. Become dependant upon the drug and gradually increased her intake. 
She was able to obtain 10 ampoules per day on prescription but would try 
and supplement this with morphine acquired without a prescription or 
diverted morphine on the black market. She would use on average around 
20-25 ampoules per day but at times used up to a maximum of 40 ampoules 
per day. Illegally obtained morphine was expensive costing up to 
MNT10,000 per ampoule. When she was not able to get morphine she 
would drink alcohol. 
B spent a short time in prison having been convicted of property theft. She 
had committed this theft in order to pay for morphine. 
Heroin  
None of the service providers, NGOs or other key informants we interviewed had any 
first hand knowledge of heroin use in Mongolia. A very small number believed that 
heroin use may occur but had no evidence to support this view. No service providers 
had treated patients who had used heroin.   
 
Of the drug users interviewed, only two reported having ever used heroin. Both reported 
only smoking the drug and both were regular morphine users.  One was a morphine 
injector the other used only oral morphine.  One stated that he had purchased the heroin 
from a friend, the other did not disclose how he obtained the drug. Of all the other drug 
users interviewed six claimed to know someone who had used heroin.  
 
None of the service providers contacted had any experience treating heroin users.  
Cannabis  
Key informants consistently identified cannabis as the most frequently used illicit non-
pharmaceutical drug in Mongolia. Most identified young people as the most common 
consumers of the drug. Many informants reported that use was prevalent amongst 
famous popular musicians and members of some youth sub cultures; “Rockers” („rock‟ 
and „heavy metal‟ music enthusiasts) were identified in particular.  Most informants had 
no evidence of this but held this belief based on anecdotal information. 
 
Among the 23 injecting drug users interviewed 8 had also used cannabis. Six of these 
eight injecting drug users had used cannabis before they had ever injected morphine. The 
other 2 IDUs had been users of morphine prior to using cannabis. Amongst the group 
interviewed it was more common for regular morphine users to have never tried 
cannabis. Those who primarily used cannabis were also less likely to have used morphine 
or other opiates.  
 
Treatment providers reported limited contact with cannabis users. The Centre for Mental 
Health and Narcology has received increasing numbers of enquires from parents 
concerned about the cannabis use of their children. The Centre offers advice and support 
where possible. Narcology clinics visited outside of Ulaanbaatar reported even fewer 
cases of cannabis users accessing their services.   
 
The National Anti-Drug Centre has in the past had contact with a small number of 
cannabis users and offered Narcotics Anonymous meetings for these clients.  
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Other illicit drugs 
There were several unverified anecdotal reports of ecstasy and amphetamine type 
substance use in Ulaanbaatar. Several key informants believed that young people from 
wealthy families, especially wealthy migrants, may use these drugs. A senior police 
representative reported that police believed ecstasy was used in some nightclubs in 
Ulaanbaatar and that the drug sold for USD50 per pill; as far as the RAR team could 
determine no person had been apprehended and charged with use of the drug to date. 
One key-informant not associated with any law enforcement agency mentioned there had 
been reports of individuals apprehended trying to import small amounts (four or five 
pills) into the country. One key-informant believed there may be a small amount of 
cocaine use among the expatriate community in Mongolia.  
Benzodiazepines 
Key informants reported that abuse of benzodiazepines, including injection, is known to 
occur. Clinicians from the Poisoning Centre reported that in the last four years there has 
been a significant increase in admissions due to benzodiazepine overdose.  
Ten of the twenty two IDUs interviewed reported using benzodiazepines; all had injected 
the drug.   
Solvents 
The abuse of solvents was widely reported by key informants to occur in Mongolia. This 
is thought to mainly occur among school aged children and particularly among the 
economically disadvantaged. 
Staff from the Centre of Mental Health and Narcology reported seeing increasing 
numbers of solvent abusing patients. The centre offers information, counselling and 
support for these clients. The National Anti-Drug Centre also offers support and 
counselling to young people who abuse solvents. 
Injecting practices in Mongolia 
Injecting drug use in Mongolia differs significantly from that which occurs in almost all 
other countries in the region.  
 
Different types of injecting practices were found to occur in Mongolia. Commonly when 
injecting within a community is investigated in order to assess the associated risks of 
HIV transmission, it is the injection of illegal drugs that is of primary interest. Other 
„types‟ of injecting were also found to frequently occur in Mongolia.  HIV transmission 
may occur in association with these different injecting practices. These are outlined 
below: 
 
The different types of injection identified were: 
1. ‘Medically supervised injecting of a pharmaceutical’: This involves injection of 
pharmaceutical medicines prescribed by a clinician and administered in a medical 
setting by trained medical  personnel; 
2. ‘Medically prescribed – self administered injecting of a pharmaceutical’: Injection of 
pharmaceutical medicines prescribed by a clinician, dispensed by a pharmacy and 
injected by the patient him/herself or by some other non-medically trained 
person; 
3. ‘Self-medicated – self administered injecting of a pharmaceutical’: Injection of a 
pharmaceutical medicine obtained over the counter from a pharmacy without a 
prescription and injected by the individual themselves or by some other non-
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medically trained person with the intention of treating some ailment or 
improving health. 
4. ‘Non-medicated – self administered injecting of a pharmaceutical’: Injection of a 
pharmaceutical medicine obtained illegally from a pharmacy without a 
prescription or on the black market and injected by the individual themselves or 
by some other non-medically trained person for a non medical reason. This may 
be considered as diversion of pharmaceuticals. 
5. ‘Injection of an illicit drug’: Injection of a prohibited substance or a controlled 
substance diverted to the black market. 
 
Injection types 4 and 5 above might be described as „illicit injecting behaviours‟. 
 
The RAR team were not able to obtain any estimates of the number of people involved 
in these different types of medical injecting or even the approximate ranking of the size 
of these populations by key informants. We were also unable to obtain pharmacy records 
detailing the quantities of injectable medications dispensed.  
 
Many key informants reported that there is a widely held perception among health care 
consumers and many medical practitioners in Mongolia (as in many other developing 
countries) that injectable medications have much greater efficacy than non-injectable 
medications. The belief that there is an association between injected medications and 
good health is also reported in many other developing countries (Reeler 2000). One key 
informant (a clinician) suggested that this belief may have arisen because oral 
medications available in Mongolia have historically been of inferior quality to injectable 
medications.  
 
Consequently medical practitioners frequently prescribe injectable medications, and many 
people obtain these preparations over the counter in preference to non-injectable 
medications. Many key informants reported that often one member of a family is 
experienced at giving injections and injects themselves and other members of the family. 
A study of injection practices in Mongolia (Logez et al 2003) reported that re-use and 
sharing of injection equipment does occur among people injecting in the home, especially 
among the poorest of the population who cannot afford new equipment for every 
injection. 
 
In a 2003 survey of drug users, the APPDO identified 27 people who had injected drugs. 
Considerable re-use of injecting equipment was reported by this group.  
 
Of the 23 respondents interviewed during this assessment who reported ever having 
injected a drug, 19 used sterile injecting equipment for all injections, one reported using 
sterile injecting equipment for most injections and two used new equipment only rarely. 
Three had used injecting equipment that had been used by another person before them. 
All IDUs reported purchasing injecting from pharmacies and eight had obtained needles 
from the APPDO (note: most of the interviews with drug users took place at the 
APPDO centre). One respondent reported being supplied needles by a friend.  
 
Only four injecting drug users interviewed had ever mixed up a drug with water prior to 
injecting. One of those injectors reported having shared this other injecting equipment. 
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Access to and availability of injecting equipment in Mongolia 
As the use of injectable preparations of prescribed medications is very common in 
Mongolia, new sterile injecting equipment such as needles and syringes can be freely 
purchased in most pharmacies. There is reportedly no stigma attached to purchasing 
injecting equipment. 
 
A number of pharmacies in Ulaanbaatar were visited during this assessment. Only a 
limited range of injecting equipment was available. Plastic disposable needles were 
stocked 3ml and 5ml volume syringes were available. In most cases syringes were sold 
with 23 gauge needles attached.  
 
The cost of purchasing one new needle and syringe ranged between MNT700 (USD0.60) 
and MNT 1200 (USD1.00). 
 
Some key informants believed that because many drug users have limited financial 
resources, they are more likely to use the money they have to purchase drugs.  
 
The NGO APPDO implements a NSP under the guidance of the NAF with funding 
from the Global Fund. USD190.00 is provided each quarter for the provision of free, 
new sterile injecting equipment and condoms to clients of this NGO. This service only 
operates one day per week. Clients are required to register in order to receive equipment 
and must sign the register every time they collect injecting equipment. Most clients 
receive 10 needles and syringes each week. Three clients used 5ml syringes while the rest 
used 3ml syringes. The syringes provided have 23 gauge, 1 inch needles attached. During 
the seven week period beginning the 1st of August 2006, the organisation provided 
injecting equipment to between 6 and 18 clients each week. Over the entire period the 
service distributed a total of 675 needles and syringes and 966 condoms. Injecting 
equipment provided by the APPDO free of charge to clients is shown in Figure 1. 
 
 
Figure 1: Injecting equipment provided by the APPDO to IDU clients free of charge. 
Drug related crime, cultivation, production and sale of illicit drugs 
There have been no reports to date of the manufacture of illicit drugs in Mongolia. A 
situation assessment conducted in 2001 (National AIDS Foundation 2001) reported that 
opium poppies and cannabis were previously cultivated by Chinese residents for 
personnel use and sale until the beginning of the twentieth century.   
 
At present cannabis, opium poppies and the ephedra plant have been reported to grow 
wild in certain areas of Mongolia. The ephedra plant is a potential source of ephedrine 
which can be used to manufacture amphetamine. A number of years ago, a Chinese 
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commercial pharmaceutical company was found to be manufacturing ephedrine from 
ephedra plant in Mongolia. This manufacturer has since ceased operation. There were no 
reports of the public using opium poppies or the ephedra plant. Some informants 
believed that Mongolian people have no knowledge of how to use these plants.  
 
Most key informants were aware of cannabis growing in areas close to the city of 
Erdenet. Among the key informants, estimates of the amount of cannabis growing wild 
in Mongolia varied between 300 and 800 hectares. Cannabis is collected and used locally 
in growing areas. It is also harvested and distributed to other centres where it is then 
sold. 
 
Two young cannabis users were interviewed and both reported that cannabis is also 
harvested in Mongolia and transported to China where it is refined first to a substance 
they termed “mud”. It is then further purified to a form which they called “kash” or 
“gash” which from the description given appears to be hashish.  
 
Hashish is imported into Mongolia and distributed for sale. One informant described 
how a “boss” imports a sizeable quantity of the drug and then distributes it among more 
junior drug dealers who then sell the drug to consumers. The junior drug dealers are 
most often young unemployed men who are grateful for the opportunity to make money.  
 
Some of the drug users interviewed said that it can be difficult to obtain hashish as 
supplies are often inconsistent.  In order to buy the drug, a potential customer must be 
known to the dealer and have his/her phone number. 
 
The RAR team was unable to access official drug related crime statistics from the 
Ministry of Justice and Home Affairs. These records are classified as secret and the 
necessary clearance could not be arranged via our counterparts in the Ministry of Health.  
 
The team was told informally that in the last ten years only 145 people had been 
convicted of drug related crime in Mongolia. Crimes included trafficking, possession and 
sale of prohibited substances. Customs officials in Sukhbaatar reported they have not 
intercepted many people attempting to traffic drugs across the land border. Police 
spoken to reported that it is difficult for police to enforce drug laws due to the weakness 
of the current legislation and the lack of guidance they receive on these matters. 
 
The RAR team was also unable to obtain permission to visit any prison facilities in 
Mongolia. We were also unable to gain access to any data on the prison population held 
by the Ministry of Justice and Home Affairs. Two of the injecting drug users interviewed 
had been in prison in the past and reported that they were able to obtain drugs while in 
prison.  
 
Other infectious diseases 
Hepatitis C virus 
Mongolia has a very high incidence of hepatitis C virus (HCV). Recent estimates of HCV 
prevalence range from 10.5% (Tellez et al 2002) – 24%. It is believed that this is may be 
due largely to the transmission from shared injecting equipment in the informal 
healthcare sector. One key informant believed that the sharing of shaving equipment is a 
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common practice among male family members and may also be a risk factor for 
infection.  
Sexually transmitted infections 
Sexually transmitted infections (STIs) account for almost half (47.4%) of all the 
infections reported in Mongolia (Thomas 2006). A total of 15,315 cases of STIs were 
reported in Mongolia in 2005. Many reports indicate an increasing trend in the incidence 
of STIs. 
 
Between 1991 and 2005 the incidence of syphilis increased from 3.70 to 9.37 per 10,000 
people in the general population. The incidence of syphilis was highest among the 15-24 
year age group. (Thomas 2006) 
 
Between 1991 and 2005 the incidence of gonorrhoea increased from 9.42 – 25.01 per 
10,000 people in the general population. (Thomas 2006) 
 
In 2005 among the general population the incidence of Trichomoniasis was 25.88 per 
10,000. (Thomas 2006). 
 
Availability of effective and early treatment for STIs is often limited, especially in rural 
areas where medical services may be poorly resourced and difficult for many people to 
access.  
 
The first highly successful condom social marketing project in Mongolia was commenced 
in 1997 by the NGO Marie Stopes International Mongolia (MSIM). This programme 
operates four reproductive health centres: two in Ulaanbaatar, and one each in Darkhan 
and Erdenet. These centres provide a wide range of reproductive health services and 
family planning methods, well woman services, male services and services specifically 
aimed at young people. The centres also do outreach work to schools, universities, 
CSWs, homeless children and in the general community. MSIM has also developed an 
education programme for Mongolia's general and private practitioners aiming to increase 
the quality and extent of family planning and reproductive health services provided in 
Mongolia.   
At-risk groups for HIV/AIDS and drug use 
When asked to rank the top five most likely methods of HIV transmission in Mongolia 
over the next decade the members of the advisory group agreed on the following order: 
1. Sexual transmission involving MSM and CSWs both equally most-at- risk 
3. Heterosexual transmission  
4. Medical injecting 
5. Illicit injecting drug use  
 
Other groups including migrant workers were also considered by key informants to be at 
risk of HIV/AIDS and drug use. 
Men who have sex with men 
Homosexuality in Mongolia is not illegal. There is no legislation however protecting 
homosexuals and other MSM from discrimination on the basis of their sexuality or 
sexual practices. These men are marginalised for their sexual practices and often face 
discrimination particularly from police. 
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The number of men who have sex with men in Mongolia is unknown. Workers from and 
NGO providing services for MSM in Ulaanbaatar estimated that there are currently 7600 
men who identify as having sex with other men. The UNAIDS website cites an unnamed 
2003 study in which 8.3% of male students reported having sex with other males. 
Notably only 50% of this group reported using condoms consistently (UNAIDS 2006) 
 
Services specifically targeting MSM are limited in Mongolia. The Together Centre is an 
NGO that receives funding from the NAF. It offers support, education and counselling 
to MSM in Ulaanbaatar. It is affiliated with the NCCD and refers all clients to there for 
STI and HIV testing.  
 
A focus group was held with MSM clients of the Together Centre. The MSM we met 
with described feeling isolated and unsupported. Many had not “come out” and were not 
openly gay; most had not disclosed their sexuality to their families.  They described 
making contact with each other via the internet or at discrete gatherings and parties in 
Ulaanbaatar.  
 
Very little drug use was reported among the MSM community. Only two of the MSM we 
interviewed reported having tried a drug, cannabis, each only on one occasion. Several of 
the MSM we spoke to had travelled overseas and had witnessed drug use in other gay 
communities.   
 
The MSM we met at the Together Centre in Ulaanbaatar all had good knowledge of HIV 
risk and prevention and all reported using condoms when they had sex. They all received 
free condoms from this CBO.  
 
There is evidence to suggest that unsafe sex is common amongst MSM. According to the 
2005 UNGASS Report (UNAIDS 2006), 17.6% of men aged under 25 and 10.3% of 
men aged over 25, 13.0% overall, reported having used a condom on the last occasion 
that they had anal sex with another man. 
Commercial sex workers 
Commercial sex work is relatively common in Mongolia and many key informants 
believed it to be increasing. In Mongolia women face a much greater incidence of 
poverty than men. This economic disparity is a risk factor for engagement in sex work. A 
punitive environment towards commercial sex workers (CSWs) in many parts of the 
country limits service providers‟ access to CSWs and also forms a barrier to sexual health 
education and promotion activities.  
 
CSWs were considered by most key informants to be one of the most-at-risk populations 
for HIV infection in Mongolia at the present time.  
 
Meetings and interviews with CSWs and organisations that work with this population 
were carried out in Ulaanbaatar, Darkhan, Sukhbaatar and Erdenet.  
 
Key informants from NGOs providing services for CSWs estimated that currently there 
are around 3000 CSWs in Ulaanbaatar, 300 in Darkhan, 30 in Sukhbaatar and 80 in 
Erdenet. Most CSWs use mobile phones to remain in contact with hotels who act to 
broker services. In small towns like Sukhbaatar, women can be easily identified if they 
work openly as „commercial sex workers‟. Many CSWs have regular clients and represent 
themselves as “casual sex partners”. There is a network of bosses (pimps) usually older, 
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female former sex workers who take a share of CSWs earnings for protection. CSWs may 
be forced to practice unsafe sex or service clients against there wishes if these bosses 
demand. Many of these bosses have arrangements with police.  
 
The majority of CSWs stated that they have to work secretly due to fear of being arrested 
by police, making it hard for support services to access these women. Some sex workers 
live in hotels and are hidden by the hotel management also making access difficult.  
 
CSWs see on average 3 clients per week (SGS 2004 data). Most clients of CSW‟s are 
Mongolian but many are foreigners most commonly Korean, Chinese and Russian. Many 
CSWs may travel overseas to work to earn better money; Russia and China are common 
destinations. 
 
The majority of CSWs stated that they were aware of the need to practice „safe sex‟ and 
frequently use condoms. According to the 2006 UNGASS Report, in 2005 94% of CSWs 
reported having used a condom with their most recent client. CSWs had limited 
knowledge concerning non-vaginal intercourse such as anal and oral sex and the risk of 
STI and HIV transmission associated with these behaviours. 
 
These figures reported for condom use are high but may not to be representative of all 
CSWs. STIs are also very common among CSWs. Some studies reporting as many as six 
out of 10 sex workers testing positive to an STI (UNDP, 2006). The high rate of STIs 
amongst most CSW populations in Mongolia suggests possibly lower condom use. 
 
Sex workers reported that it was often difficult to insist upon using a condom when 
having sex with clients as many clients do not like sex with a condom, may offer to pay 
for sex with out one and may even ask for another sex worker who will perform the 
service without using one. They also reported that clients are often drunk which makes it 
harder to negotiate for safe sex.  
 
The majority of the CSWs drink alcohol with their clients. Excessive alcohol 
consumption is a common behaviour among sex workers. Comments by sex-workers 
included: „We buy Vodka before we go to the hotel‟, „Drinking alcohol before sex is 
something quite normal - it is part of our tradition and culture‟. Some of the CSWs stated 
that they had to be careful not become drunk if they wanted to protect themselves from 
some harmful behaviours. Some commented that they were more likely to not use a 
condom if they are intoxicated.  
 
Violent incidents including physical and verbal abuse experienced by CSWs were 
reported to commonly occur. CSWs said they generally accept this violence without 
reporting it to police as there is the risk that they may be arrested themselves. 
 
Several key informants believed that CSWs operating in mining areas are at very high risk 
of syphilis due to the very high prevalence of syphilis among male mine workers and 
pregnant women in these areas. 
 
There is little evidence of significant levels of drug use among CSWs in Mongolia. None 
of the participants in the group discussions reported ever having used drugs such as 
cannabis, heroin, morphine or other opiates, ATS, ecstasy or cocaine or any other legal 
or illicit drugs.  
 
  38 
The majority of participants in the focus groups stated that they were also not aware of 
having any clients who had used drugs (apart from alcohol). Two participants reported 
knowing clients who used drugs but were unsure of what type of drugs. Participants in 
one group reported an incident that occurred 2-3 years ago in Ulaanbaatar when a client 
asked a CSW if she would like to inject drugs with him before having sex – it is 
understood that the CSW refused. 
 
Some CSWs who had travelled to China to work reported that in some border areas 
seeing people “use a white substance” that is sniffed or taken orally that results in them 
looking „blank‟ or „going stupid‟.  
 
The majority of interviewees stated that their principal source of information on HIV 
and safe sex practices is education and training provided by the local NGOs. The sex 
workers we spoke to were all literate, but the availability of written information material 
about HIV/AIDS and drugs is limited. The majority of CSWs have not seen educational 
TV programs about HIV/AIDS because they usually work at night time when these 
programmes are shown. 
 
The interviewees felt there was insufficient information on drugs and related issues and 
places where they could get counselling or simply information about these issues. This is 
confirmed by the statements of other key informants 
 
A number of NGOs receive funds from the NAF to work with CSWs. These include: 
the Women’s Trust Association in Darkhan, the HIV/AIDS Protection Organization in 
Erdenet and the Public Health Professionals Association. These NGOs have local as well as 
national programs with peer educators providing CSWs with group and individual 
counselling, advocacy and support.  
 
A trial of the 100% Condom Use Program (100% CUP) was launched in Darkhan in 
2002 with support from the WHO. The trial proved to be very successful. The syphilis 
rate among CSWs fell from 26% in 2002 to 14% in 2004. CSWs reporting consistent 
condom use increased from 26% in 2002 to 74% in 2004. Ongoing funding for the 
program was not secured. At the time of preparing this report there were plans for the 
GFATM to provide ongoing funding for this initiative and for eventual implementation 
across the country.  
 
Sex workers in Darkhan are also issued with a “green card” when they attend a clinic for 
monthly sexual health screening. Holding this green-card renders them immune from 
arrest if apprehended by police for engaging in sex work. NGO workers feel this 
initiative in particular has been very successful in promoting safe sex and improved 
sexual health among sex workers and has fostered a more understanding among police 
towards sex workers.  
Migrant workforce 
Many key informants suggested that the increasing numbers of migrant workers, 
particularly from China employed in the construction and mining industries, may 
represent a population where injecting drug use and HIV may occur. A focus group was 
held with Chinese construction workers in Ulaanbaatar. This group had very little 
knowledge of injecting drug use. They were also very isolated. None spoke Mongolian 
and all of them described how they rarely left the building site where they worked and 
were also accommodated for fear of being harassed by police. They reported that it was 
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not uncommon for police to detain them and require payment of a fine before they 
could be released.  
 
Drug use and HIV in neighbouring regions 
Neighbouring China and Russia both have significant HIV epidemics and high levels of 
injecting drug use. The spread of HIV through injecting drug use is a major contribution 
to the HIV epidemics in both these countries.  
 
There are increasing levels of trade and movement between Mongolia and as such the 
trends relating to HIV and drug use in these neighbouring countries especially in the 
nearby urban centres of Irkutsk and Ulan Ude in Russia and Hoh Hot in China may have 
some impact upon the Mongolia.  
Russia 
The number of people in Russia testing positive for HIV has grown exponentially in the 
last two decades.  
 
Since 1999 there has been an increase in the prevalence of HIV in Irkutsk. According to 
the Russian Federal AIDS Centre there have been 19,887 cases of HIV registered in the 
Irkutsk region between 1 January 1987 and 30 June 2006. Of these, 85 people have died. 
The prevalence of HIV in Irkutsk is 778 per 100,000 which is considerably higher than 
the prevalence of HIV in the entire Russian federation which of 235 per 100,000. Sixty 
percent of people infected with HIV are aged between 20 and 29 years. 
 
By far the largest at-risk group is IDUs. In 2005 IDU was the main risk factor for HIV 
infection in Irkutsk, associated with 80.7% of new infections.  In 2004 5% of IDUs in 
Irkutsk tested by the Russian Federal AIDS Centre we found to be HIV positive – ten 
times greater than the rates measured in the general population in Irkutsk and more than 
2.5 times the rate measured among overall IDU population in the Russian Federation.  
 
Heterosexual transmission of HIV is also increasing as is the spread to the general 
population beyond IDU groups. Unsafe sex also increased in the commercial sex 
industry where drug use is also prevalent. A significant increase in STIs has also been 
reported in this region.  
 
Harm reduction services are being introduced in the region despite the Irkutsk 
government having been originally opposed to such measures. The drug scene in Irkutsk 
is described as fairly open which affords services good access to IDU populations.  
China 
The HIV epidemic in China is recognised as having spread to all provinces by 1998. By 
the end of 2003 between 650,000 and 1,020,000 people were estimated to be living with 
HIV/AIDS in China, equivalent to a prevalence rate of around 0.07% in the general 
population (State Council AIDS Working Committee Office 2004). 
 
Significant regional variation exists within the country. The incidence of HIV in the 
Inner Mongolia Autonomous Region is very much lower than many other provinces. By 
September 2004 the number of reported HIV cases in the province was fewer than 100. 
While in some regions the prevalence rate among IDUs is as high ass 50%, it is lower 
than 5% in Inner Mongolia. The prevalence rate among CSWs in the region is less that 
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0.1%. The main rout of transmission throughout China is via injecting drug use. There is 
evidence across the country that the sexual transmission is becoming increasingly 
common and the epidemic is spreading into the general population. This is especially true 
in areas with high rates of HIV among IDUs and CSWs. (State Council AIDS Working 
Committee Office 2004)   
 
IDU is increasingly prevalent in China. Currently there are around 1.14 million registered 
illicit drug users in China (Chu & Levy, 2005). This figure is likely to represent only a 
small proportion of the drug using population. Others have estimated that there may be 
as many as 3.5 million IDUs in the country (Aceijas, Stimson, Hickman, & Rhodes, 
2004). Significant regional variation in drug use is known to occur within China; however 
the RAR team was unable to obtain information concerning drug use in Inner Mongolia 
specifically.   
 
Efforts have been made by the government of China to make Inner Mongolia „drug free‟. 
Authorities claim that in some areas theses attempts have been successful through the 
implementation of strict prohibition laws and compulsory treatment strategies (National 
Narcotics Control Commission, 2005). The RAR team were unable to find evidence 
verifying these claims.  
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Discussion  
Probable sources of HIV spread in Mongolia in the next decade 
The starting point for any rational effort to develop an effective response to the threat of 
HIV in Mongolia has to be an attempt to identify the most serious sources of this threat.  
 
Injecting drug use and HIV in Mongolia 
There is a strong consensus that illicit injecting drug use, as seen now in virtually every 
other country in Europe and Asia, is fortunately still quite rare in Mongolia. We found no 
evidence of significant injecting drug use in Ulaanbaatar and the cities of Erdenet, 
Darkhan or Sukhbaatar, despite extensive efforts to identify injecting drug users or 
evidence of their existence. We found no evidence of the usual complications of regular 
and frequent injection of street drugs by young people such as fatal and non-fatal 
overdoses, local infections at the injection site (e.g. abscesses, cellulitis), distal infections 
(e.g. endocarditis, brain abscess) or social problems (e.g. property crime). It is not 
possible to ever completely exclude the possibility that a substantial population of 
injecting drug users exists but is well hidden or was missed. We believe this to be most 
unlikely. It was not possible to obtain an estimate of the number of illicit injecting drug 
users or even minimum and maximum estimates. It is generally agreed that there are 
more people in Mongolia involved in medical injecting with non-sterile equipment than 
illicit injecting drug users.   
 
A significant issue in the health care sector is self administration of prescribed morphine 
by patients with chronic non-malignant pain (CNMP). Some inject 10-15 ampoules of 10 
mg morphine a day intra-venously or intra-muscularly for many years. Most of these 
patients are known only to their doctors. Some go on to develop morphine dependence 
and supplement their prescribed morphine with additional supplies obtained from the 
black market. It is difficult to get estimates of the number of such patients in Mongolia 
or even minimum and maximum estimates. CNMP can be more effectively managed by 
oral slow release opiates or other non-opiate medications (Harden 2002). While cost may 
be a barrier to the introduction of such management in Mongolia these alternatives 
should be explored further especially as they avoid the risk of HIV and BBV 
transmission associated with injectable preparations.  
 
Medical injecting and HIV in Mongolia 
For the purposes of this discussion medical injecting refers to all forms of skin 
penetration in both the formal and informal or traditional health care sectors. This 
includes the very common practice in the formal health care sector in Mongolia of 
injecting a variety of medications including vitamins, antibiotics, analgesics and fluids 
although many of these can be administered just as well by oral or other non-parenteral 
means. In the traditional health care and other sectors, skin penetration includes a diverse 
range of practices including injections, tattooing and ear-piercing. It was not possible to 
obtain an estimate of the number of patients in Mongolia involved in medical injecting or 
even minimum and maximum estimates.   
 
It is likely that in Mongolia as in many other developing countries injecting practices may 
sometimes involve the re-use of injecting and other skin penetration equipment without 
adequate sterilization. Such practices are a significant risk for the transmission of HIV 
and other BBVs. In Mongolia, these risks are clearly greater in the informal and 
traditional health care system where the re-use of inadequately sterilised injecting 
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equipment or other skin piercing equipment appears to be more common than in 
hospital settings.  
 
Further support for the notion that medical injecting is a potential source of HIV comes 
from consideration of hepatitis C data in Mongolia. The prevalence of HCV in the 
general population is remarkably high in comparison with other countries. Widespread 
use of inadequately sterilised injecting and other skin piercing equipment in the formal 
and traditional health care and other sectors is the most plausible explanation for the 
high HCV prevalence reported in Mongolia. Although HCV is more easily spread via 
blood-blood transmission than HIV, this high prevalence of HCV is an indication that 
HIV has the potential to also be spread by injection related transmission in Mongolia.  
Men who have sex with men and HIV in Mongolia 
MSM account for almost half of all known HIV infections in Mongolia to date. This 
suggests that MSM have to be considered as a very likely source of a generalised HIV 
epidemic in Mongolia in the next decade. However, in most countries, the spread of HIV 
from MSM to the general population has only been moderate. This is likely to also be the 
case in Mongolia. In the absence of evidence to the country we have assumed that MSM 
in Mongolia are most likely to have similar sex behaviour to MSM in most other 
countries. If this is in fact the case, then the risk of a generalized epidemic being triggered 
by an earlier HIV epidemic among MSM is likely to be no more than moderate. In 
addition, estimates of the number of MSM in Ulaanbaatar (and then extrapolated out to 
the population of Mongolia) are surprisingly low. It may be that these estimates are 
reasonably accurate. Alternatively, the true number may be somewhat higher than these 
estimates. We doubt that the true number of MSM is lower than the estimates. It is very 
possible that under-reporting of MSM numbers may be a reflection associated stigma. 
Importantly stigmatised populations are harder to provide services for and are also at 
greater risk of engaging in riskier behaviours.  
Commercial sex workers and HIV in Mongolia 
There appears to be is a sizeable population of CSWs in Mongolia, many of whom, on 
the available data, appear to have unprotected sex. In turn, it can be safely assumed that 
clients of CSWs have sex with many other female partners (including their wives and girl 
friends). Accordingly, we rate CSWs as at least an equally likely source of an HIV 
epidemic in Mongolia in the next decade to MSM even though MSM have accounted for 
more HIV cases in the country thus far.  
 
STIs are a potent potential risk factor for the spread of HIV in the country and thus STIs 
are rightly  considered a serious public health problem in Mongolia (UNDP, 2006) 
 
The fact that 11 of the 25 (44%) reported cases of HIV infection in Mongolia also had 
Syphilis or Gonorrhoea, that the prevalence of STIs in Mongolia is known to be 
alarmingly high, and that the important role of STIs as facilitators of sexual transmission 
of HIV is well established suggests the urgent need for rapidly expanding and improving 
the effectiveness of STI policy and practice in Mongolia. The very high prevalence of 
STIs in Mongolia will unfortunately facilitate HIV sexual transmission both among MSM 
and also between CSWs and their clients, and beyond.  
 
Sexual transmission of HIV among the heterosexual population 
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In addition to the potential spread of HIV from CSW to the wider heterosexual 
population as discussed above it is important to consider factors likely to increase the 
sexual transmission of HIV within the heterosexual population. 
 
Although the high prevalence of STIs in Mongolia is a great concern, heterosexual 
transmission independent of CSW appears a much less likely source of significant 
numbers of new HIV infections in Mongolia, at least for the next decade. However, 
given heterosexuals represent a large proportion of the population and the high 
prevalence of STIs in Mongolia, even a low incidence of HIV in this population could 
potentially over time account for a large number of cases.  
 
Specific risk factors likely to increase the spread of HIV within the heterosexual 
population include widespread injecting practices and unsafe sex. Alcohol intoxication is 
a well documented risk factor associated with risky sexual behaviours. This is of 
particular concern in Mongolia given the relative affordability, availability and widespread 
use of alcohol. 
 
Accordingly, our ranking of the most likely sources of significant HIV infections in 
Mongolia in the next decade is: 
1. Sexual transmission involving men who have sex with men (MSM) & 
Commercial Sex Workers (CSWs) 
3. Sexual transmission among the heterosexual population  
4. Medical injecting 
5. Illicit injecting drug use (IDU)  
Is injecting drug use likely to increase in Mongolia in the foreseeable 
future? 
Experience in other countries has demonstrated the difficulty of controlling IDU 
triggered HIV epidemics. HIV epidemics amongst IDU populations in the community 
and prison populations can rapidly spread to the general population.  
 
At present the risk of an IDU driven HIV epidemic in Mongolia is low given the likely 
number of IDUs in Mongolia is very small. However there are a number of readily 
identifiable factors which suggest that Mongolia could experience a rapid growth in the 
number of injecting drug users in the foreseeable future. Mongolia‟s two neighbours, 
Russia and China, had virtually no injecting drug use until the last couple of decades. 
Both countries experienced an epidemic of injecting drug use quickly followed by an 
HIV epidemic among and from these injecting drug users.  Other risk factors include: 
the very young age of the Mongolian population with 70% of the population under the 
age of 35 years and around 33% under the age of 16 years; youth unemployment is very 
high; there are an increasing number of pockets of wealth; Mongolia has become a transit 
country for the trafficking of drugs between Russia and China; and road and rail 
communication is limited now but is improving rapidly.  
 
Certain factors exist that may limit the increase of injecting drug use in Mongolia in the 
near future. Given alcohol is a prevalent and culturally accepted drug in Mongolia it is 
unlikely that a large proportion of the population would commence using an alternative 
intoxicant such as injectable drugs such as heroin that are harder to obtain, more 
expensive and less culturally acceptable. Mongolia appears to lack any significant existing 
illicit drug market and drug distribution network of and is a long way from the major 
heroin producing countries. There is some evidence however that such drug distribution 
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networks are beginning to be established but are currently limited to the distribution of 
cannabis and related products. These networks have the potential to expand and be the 
basis of a larger drug distribution mechanism. Counter to the development of such drug 
distribution are factors such as Mongolia‟s long and very cold winters, poor transport 
infrastructure and common nomadic lifestyle practiced in rural areas and relatively small 
and low density population.  
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RECOMMENDATIONS 
1. The Government of Mongolia should recognise the potentially severe 
health, social, economic and security costs of an uncontrolled HIV 
epidemic in the country and accept that HIV control is of paramount 
importance. 
 
2. Strong political leadership is needed to ensure that pragmatic responses to 
the HIV epidemic are formulated and adopted rapidly. These responses 
must be implemented now and expanded to scale as soon as possible. For 
this to occur, strong political support and adequate funding is essential. 
Countries that have been successful in controlling HIV acted quickly in the early 
stages of the epidemic. This was possible only with strong political support by 
the country‟s leaders.  
 
3. Increased funding must be made available for heath and social 
interventions in HIV prevention. These interventions must target the 
wider community and have particular focus on at risk groups including 
commercial sex workers, men who have sex with men and injecting and 
other drug users. It is important to recognise that while the costs of these 
exercises may be considerable, the future costs of inadequate action will be many 
times greater. It is also important to recognise that many of those most at risk are 
members of marginalised groups in Mongolian society.  
 
4. The Ministry of Justice and Home Affairs and the Ministry of Health 
should collaborate to formulate policy relating to illicit drug use and 
HIV/AIDS. A harm minimisation approach to issues should be taken. The 
prevention of HIV transmission associated with injecting drug use has been 
demonstrated in other countries to be most successfully achieved by taking a 
harm minimisation approach and has been explicitly endorsed by numerous 
United Nations and WHO statements and Declarations4 . 
 
5. Within the general community awareness of HIV/AIDS and its associated 
risks and the effectiveness of prevention must be raised and maintained. 
Current levels of HIV/AIDS knowledge are low. The community must 
understand and support the need for pragmatic measures to control HIV in 
Mongolia. 
 
                                                 
4
 1974, 1992 & 1996 reports of the WHO Expert Committee on Drug Dependence; 1988 UN 
Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances; 1998 Declaration on 
the Guiding principals of Drug Demand Reduction by the UNGASS on the World Drug Problem; 
Preventing the Transmission of HIV among Drug Abusers: A Position Paper of the UN System, 2000; 
2001 UNGASS on HIV/AIDS Declaration of Commitment on HIV/AIDS; 2003 WHO Global Health 
Sector Strategy for HIV/AIDS; 2003 WHO Regional Committee for the Western Pacific Resolution 
WPR/RC54.R5: Sexually Transmitted Infections Including HIV/AIDS; 2003 Treating 3 Million by 
2005: Making it Happen: The WHO Strategy; 2004 WHO/UNODC/UNAIDS Position Paper on 
Substitution Maintenance Therapy in the Management of Opioid Dependence and HIV/AIDS 
Prevention; 2005 UNAIDS Committee of Cosponsoring Organisations Joint UNAIDS Statement on 
HIV Prevention and Care Strategies for Drug Users; 2005 Intensifying HIV Prevention: UNAIDS 
Policy Position Paper as well as numerous other documents and statements. 
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6. Continue and strengthen HIV surveillance measures. Assess yearly the 
need to include IDUs as a sentinel group in second generation 
surveillance of HIV in Mongolia and continue to question other sentinel 
groups about injecting drug use. Improving the quality and quantity of data 
will assist Mongolia to respond to the HIV epidemic successfully. Currently there 
are insufficient numbers of IDUs to warrant their inclusion as a separate sentinel 
group but this may change.   
 
7. Surveillance should be carried out to detect the emergence of IDUs in 
Mongolia. Surveillance should involve the following indicators: drug overdose 
deaths; incidence of possible IDU related illness (admissions for unexplained 
abscesses and cellulitis in arms and legs that may be associated with IDU; 
endocarditis, brain abscess, lung abscess); drug related crime; drug treatment 
statistics; interviews with families of young people who have died suddenly to 
assess whether the number of injecting drug users is increasing. Methods used 
should complement and extend any existing reporting procedures.  
 
8. Strengthen STI policy and practice as a matter of urgency, including 
prevention, treatment and care, particularly amongst CSWs, MSM and 
IDUs. There are very high rates of STIs in Mongolia; STIs facilitate the 
transmission of HIV and must be brought under control as soon as possible. n. 
School and community based education improved access to early diagnosis and 
care would be included in a comprehensive STI control strategy. 
 
In particular condom use must be promoted in the general community, and with 
a particular focus on at-risk groups. There is a need to rapidly reduce the risk of 
further HIV infections and greater condom use will assist with this. It is 
important to ensure that particular groups, such as MSM, have access to 
condoms and it may be necessary to expand availability to cater to the needs of 
this and other groups. It is important to recognise that the high prevalence of 
STIs in Mongolia will not substantially decline for some time even if vigorous 
efforts are made soon. Efforts need to be sustained to bring about a benefit in 
the long term. 
 
9. Preparations should be made to expand ARVT. While there is currently only 
a very small number of people requiring ARVT, given the rate of increase in the 
incidence of HIV in Mongolia this is likely to change in the near future. It is 
important to ensure that the necessary clinical capacity exists and access to 
medications is guaranteed.   
 
10. Expand capacity to treat HCV, especially in HIV positive people. Given 
the high incidence of HCV in Mongolia it is likely that there will be increasing 
numbers of HCV positive HIV patients. Treatment of both infections is essential 
but can be complicated.   
 
11. Encouraging increased use of voluntary counselling and testing (VCT) by 
CSW, MSM, IDU and in the wider community. It is critical to ensure that 
testing is voluntary and that appropriate counselling is available. Those at risk of 
HIV infection should be made aware of the benefits of testing and early 
detection. Access to VCT should be made as straightforward as possible.  
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12. Targeted education campaigns must exist for MSM, CSWs and IDUs. The 
particular needs and risks experienced by these groups must be addressed in 
targeted education campaigns. To effectively reach these groups and 
communicate important information the material produced may not be suitable 
for the distribution to the general population. Sensitive distribution may be 
necessary but should not hinder communicating important messages to these 
groups.  
 
13. Ensure further expansion of the  100% condom utilisation programme 
(CUP) in the commercial sex work industry The most urgent requirement for 
reducing the risk of HIV spread between CSWs and their clients is to make the 
100% Condom Utilisation Programme (CUP) national with 100% 
implementation. Localized implementation has been very successful. This is not 
surprising as the Mongolian programme was modelled on a highly successful 
programme implemented in Thailand.  
 
14. Encourage community development within IDU, CSW and MSM 
populations and develop an anti discrimination framework for these at risk 
groups.  Protecting the human rights and reducing the stigma experienced by 
target populations will facilitate HIV prevention. Encouraging collective action 
through community development can enable CSWs to resist pressures to engage 
in unsafe sex with clients. Safe spaces for MSM to gather are important and can 
facilitate access to HIV prevention services.  
 
15. Review legislation concerning CSWs and MSM to ensure that their legal 
status does not impair the objective of HIV control. Laws criminalising sex 
work and/or discriminatory action against these groups by police can hinder 
access to services and further marginalise these groups consequently increasing 
the likelihood of engaging in risk behaviours. Offering police training regarding 
these difficult issues and introducing police liaison officers to work with these 
communities has proved successful in other countries. It is necessary to educate 
police on the rationale and importance of HIV prevention measures such as 
harm reduction, so that they can use this knowledge in their application of the 
law.   
 
16. Consider methods, such as regulating commercial sex work, to encourage 
a shift from street based sex work to fixed sites. Street based sex work offers 
the least protection for CSW and provides the most difficult environment for to 
decline clients who refuse to use a condom. In other countries regulation which 
shifts CSW from the street to fixed sites has been shown to reduce HIV 
infection. 
 
17. Reducing the re-use of un-sterile injecting equipment in the formal and 
informal health care systems as well unsupervised household injecting. 
High rates of HCV in the general population suggest unsafe injecting and skin 
penetration practices particularly in the informal health sector.  
 
18. Increase the availability and decreasing the price of appropriate injecting 
and other skin piercing equipment. Access to new sterile injecting equipment 
is an optimal way to prevent injecting related BBVs infection. Shorter small gauge 
needles are more appropriate for intravenous drug use than the long, large gauge 
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needles currently available as small needles result in less tissue and vein damage 
and contain less dead space.  
 
19. Introduce regulation of body modification services (including piercing and 
tattooing services) and provide guidance on safe practice to these service 
providers. 
 
20. Reduce the incidence of avoidable injections by educating health care 
providers and the wider community of the associated risks of this practice 
and the benefits of non-injectable medications. 
 
21. Improve regulations controlling the distribution of pharmaceutical opiates 
so to prevent the diversion of these drugs. Evidence of significant amounts of 
pharmaceutical opiates available on the black market suggests tighter controls are 
required.  
 
22. Identify patients who are managed for prolonged periods with frequent 
opiate injections for the treatment of chronic non-malignant pain. Many 
patients who receive injectable opiates for the management of chronic non-
malignant pain remain hidden. This group is at risk of developing drug 
dependence and BBV transmission. 
 
23. Develop protocols for management of patients with chronic non-
malignant pain who are prescribed injectable opiates. This should aim to 
achieve a gradual transition to treatment using non-injectable sustained release 
opiates and non-steroidal anti-inflammatory drugs which are more effective in 
the management of pain and do not carry the associated risks of BBV 
transmission. 
 
24. Increasing the provision of non-judgemental, factual and evidence based 
drug education in schools and in the community. It is critical that this 
education does not pass judgment on people who use drugs. It should also be 
balanced and factual. Young people often have an intuition that drug education is 
inaccurate and strongly biased against drugs. If this is how they perceive drug 
education, then they will be wary about accepting it and any future drug 
education messages.  
 
25. Improve the quality of drug treatment by expanding the range of evidence 
based treatment options available and enhance staff capacity. Effective 
treatment requires reasonable treatment facilities and motivated well trained staff 
who are kept up to date with developments in the alcohol and other drug fields. 
It is essential that clinicians receive ongoing training and have access to 
international literature. Local research must also be encouraged as this improves 
quality of services offered and enhances the capacity of staff and improves their 
practice. This will required increased funding. 
 
26. Consider international training for key drug treatment staff. Current drug 
treatment available in Mongolia is limited considerably by the lack of experience 
of healthcare professionals responsible for providing care. The most effective 
way to quickly increase their capacity is provide these professionals with exposure 
to practices in other countries where drug treatment services are more developed. 
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27. Prepare for methadone maintenance treatment for when the needs arises. 
Currently there is little need for Mongolia to provide MMT. However this need 
may well occur very quickly in the near future. It is important that Mongolia has 
the capacity to respond to such a need promptly. Having available an evidence 
based response such as MMT is an important step to reducing drug demand and 
preventing HIV.  
 
28. Be prepared to expand Needle and Syringe Program quickly for when 
there is some indication of increasing injecting drug use. To respond to an 
emerging IDU population it may be most efficient to develop „secondary‟ NSPs 
that operate through existing health services. This requires minimal additional 
resources but achieves wide coverage.  
 
29. Review legislation and law enforcement concerning drug use and ensure 
that this does not impair the objective of HIV control. It is critical that 
people who use drugs can access drug treatment and HIV prevention services 
such as NSP programs without fear of being charged for drug offences. Police 
should receive guidance on how to enforce drug laws while also taking a harm 
reduction approach and ensuring that HIV prevention measures are successful.  
 
30. A balanced approach to drug law enforcement must be taken. Ensuring that 
law enforcement assists rather than undermines HIV prevention is critical. By 
focusing all efforts on drug supply reduction and too little on demand and harm 
reduction there is a very real risk of precipitating an increase in the transition 
from non-injecting drug to injecting drug use. The unfortunate failure of such an 
unbalanced approach has been demonstrated in a number of countries.  
 
31. The Government of Mongolia needs to consider a comprehensive range of 
approaches to reduce the severe problems associated with the excessive 
consumption of alcohol including the exacerbation of unsafe sex practices 
by intoxicated persons. Alcohol clearly increases the likelihood of unprotected 
sex. While the risks of HIV transmission associated with this may be considerably 
less than those seen in other at risk groups it is still critical to address this issue 
especially as Mongolia has very high rates of alcohol consumption.  
 
32. The Government of Mongolia must conduct ongoing evaluation and 
monitoring of HIV control programs. This will ensure higher quality programs 
and will allow for any negative consequences to be identified and minimised. 
Evidence of the success of HIV control programs is necessary to justify their 
operation. This is particularly important when some measures may be 
controversial and may be seen as objectionable by some critics. This evidence can 
safeguard the political sustainability of such programs.  
 
In summary, it is critical for Mongolia that the current low prevalence of HIV in the 
country is maintained indefinitely. Early and vigorous action responding to the multiple 
areas of risk will avoid an HIV epidemic in the country. As in other countries which have 
managed the HIV epidemic well, this will require strong political leadership and effective 
collaboration between health and justice ministries and government and non-government 
sector. The cost of action may seem rather high but this does not compare with the 
much higher cost of inaction.  
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Appendix I: Timetable of meetings, site visits and activities 
Day and date Time Activity 
Monday 04/09/06 09.30-10.30 Meeting with WHO Country Office staff: Mr Hagan (WR), Dr 
Govind, Dr Jargalmaa 
   
 11.00-12.30 Meeting with Dr Kazantseva, Centre for Mental Health and 
Narcology (CMHN) 
   
 15.00-15.15 Meeting with students from the School of Public Health 
   
 16.00-16.30 Meeting with Dr Munkhdelger, Head, Pharmaceuticals and Medical 
Devices Department, Ministry of Health  
   
Tuesday 05/09/06 10.00-11.30 Meeting with Mr Bayaraa, President, Association Against Alcoholism 
and Drug Abuse 
   
 12.00-13.15 Meeting with the Vice-Minister of Health, Ministry of Health 
   
 16.30-17.30 Meeting with Dr Enkhjin, Officer in charge HIV/AIDS, Ministry of 
Health GFATM projects 
   
Monday 11/09/06 10.00-10.50 Meeting with Dr Khongorzul, Dr Nai Tuya and Dr Kazantseva, 
CMHN 
   
 11.00-13.00 Advisory Group Meeting 
   
 14.00-16.00 Site visit to CMHN 
   
Tuesday 12/09/06 11.00-13.30 Site visit to APPDO 
   
 14.30-17.45 Meeting with WHO volunteer 
   
 16.00 – 16.45 Teleconference with WHO REGIONAL OFFICE FOR THE 
WESTERN PACIFIC 
   
 17.00 - 18.00 Meeting with students from School of Public Health 
   
Wednesday 13/09/06 09.00 -09.45 Interview training with students from School of Public Health 
   
 10.00-16.00 Interviews with drug users at APPDO 
   
Thursday 14/09/06 09.30 -11.30 Meeting with Dr Enkhjin, Ministry of Health 
   
 14.30-17.00 Interviews with drug users at APPDO 
   
 14.30 – 17.00 Focus group with CSWs 
   
 17.30 -19.00 Interview training and briefing with students from School of Public 
Health 
   
 19.30 – 20:30 Meeting with Clinicians from international SOS clinic  
   
Friday 15/09/06 09.00 - 10.00 Meeting with Dr Kazantseva, CMHN 
   
 10.15 - 11.00 Meeting with Ms Munkhdelger, Ministry of Health 
   
 11:00 – 12.15 Meeting with Major Nyamdorj Nyamtseveen & Ms Chimedregzen, 
Criminal Police Department 
   
 13:15 – 14.15 Meeting with Ms Batsukh Altantsetseg, director NAF 
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 17.00 – 17.30 Meeting with Dr Enkhjin Ministry of Health 
   
Monday 18/09/06 11:00 – 12:30 Meeting with Mr Dashtudev and Mr Bat-Amgalan, Ministry of 
Justice and Home Affairs 
   
 13:30 – 15:00 Meeting with students from School of Public Health 
   
Tuesday 19/09/06 10:00 – 11:00 Meeting with Mr Enkhbayar, City Health Department 
   
 14:00 – 15:00 Meeting with Ms Munkhtsatseg, Inspector, National Inspection 
Agency 
   
 22:00 – 23:30 Meeting with CSW, Women‟s Trust Association and Sexual Health 
Specialists, Darkhan 
Focus group with CSWs 
   
Wednesday 20/09/06 10:00 – 11:30 Site visit to HIV/AIDS and Sexual Health Departments, 
Government Health Centre, Darkhan 
   
 11:00 – 12:00  Site visit to Narcology Centre, Darkhan, Dr Oyunchimeg 
   
 12:00 – 13:00 Site visit to Women‟s Trust Association Centre, Darkhan 
   
Thursday 21/09/06 09:00 – 10:30 Meeting with Mr Azbayar, Head, The National Anti-Drug Centre 
   
 10:30 – 11:30 Meeting with Dr Enkhjargal, Railway Hospital 
   
 18:30 – 20:00 Interview with drug user  
   
Friday 22/09/06 14:00 – 16:00 Meeting with Dr Janchimeg, Ms Narentuya, HIV/AIDS Protection 
Organisation,  
   
 16:00 – 17:00 Teleconference with NDARC 
   
Monday 25/09/06 10:00 – 12:00 Advisory group meeting 
   
 13:00 – 14:00 Meeting with student from School of Public Health 
   
 14:30 – 15:30 Meeting with Mr Dungerdorj, National Officer HIV/AIDS, 
UNICEF 
   
 15:30 – 16:30 Meeting with Ministry of Health representative in charge of SGS of 
HIV 
   
 17:00 – 17:30 Meeting with Students from School of Public Health 
   
 17:30 – 18:30 Interviews with drug users 
 
Tuesday 26/09/06 09:00 – 10:00 Meeting with Dr. Unur, Statistician, Department Of Health, 
Sukhbaatar  
   
 10:00 – 11:00  Site visit to Narcology Centre, Sukhbaatar, Dr Ganchimeg 
   
 11:00 – 13:00 Site visit to STIs/HIV Training & Prevention Centre, Sukhbaatar, 
Dr. Delgersaikhan 
   
 13:00 – 14:00 Meeting with Mr U. Sainnyam, Head, Branch Office of the 
Association Against Alcoholism & Drug Abuse, Sukhbaatar 
   
 15:30 – 16:30  Meeting with Head of Police Department, Sukhbaatar. 
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 15:30 – 16:30 Meeting with Ms Byambaa & Dr Bayannas, Ministry of Health, 
Global Fund supported projects to fight HIV/AIDS & TB, 
Ulaanbaatar 
   
 16:30 – 17:30 Meeting with Mr Mendbayer and Mr Gartogoo, Together Centre, 
Ulaanbaatar 
   
 17:00 – 19:30 Meeting with officer in charge of customs at Mongolia - Russia 
border crossing 
   
Wednesday 27/09/06 09:00 - 09:30 Meeting with Dr. Unur, Statistician, Department Of Health, 
Sukhbaatar 
   
 09:00 – 09:30 Meeting with Dr Khun, Ministry of Health, Ulaanbaatar 
   
 10:00 – 11:30 Meeting with Delia Barcelona, Representative, & Dr Enkhjargal, 
UNFPA 
   
 10:00 – 11:00 Meeting with Dr Ganchimeg, Narcology Centre, Sukhbaatar 
   
 12:00 – 13:00 Meeting with Dr Erdenebeyr, Director, CMHN 
   
 11:20 – 13:45 Meeting with Mrs. Horolsorin, Director, NGO (branch) Against 
Violence, Sukhbaatar 
   
 14:00 – 13:00 Meeting with Dr Daigiymaa, Director, Department of Forensic 
Medicine, National Centre of Forensic Investigation 
   
 16:00 – 16:30 Meeting with Gundalai Lamjov, Minister of Health 
   
 16:30 – 17:30 Meeting with Dr Naymjav, Director HIV/AIDS STI department, 
NCCD 
   
 18:00 – 19:30 Meeting with Dr. Dolzmaa, psychologist & head, Centre for Alcohol 
& Narcology, Erdenet 
   
 19:30 – 20: 30 Meeting with senior police officer, Erdenet 
   
 20:45 – 23:00 Meeting with CSW NGO, Erdenet 
Focus group with CSWs, Erdenet 
   
Thursday 28/09/06 08:30 – 09:00 Meeting with Dr. Ganhuyag, Director, Health Department, Erdenet  
   
 09:00 – 10:00 Meeting with Dr. Cowelmae, head, STIs Department, Government 
Health Centre, Erdenet  
   
 09:00 – 11:00 Site visit to National Trauma Hospital, Ulaanbaatar, Dr Nansalma 
   
 10:00 – 11:00 Meeting with Dr Dolzmaa, Narcology Centre, Erdenet 
   
 11:30 – 12:30 Meeting with Mr Jargalsaikhan, head, Foundation Against 
HIV/AIDS and Drug Abuse  
   
 11:30 – 12:30 Meeting with Dr. Oyanchimeg, psychologist, Narcology Hospital, 
Erdenet 
   
 12:30 – 13:30 Meeting with school Social Worker, School 8, Erdenet 
   
 12:30 – 14:00 Meeting with Mr Yurnaa, head of youth division, APPDO 
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 13:30 – 14:30 Meeting with trauma physician, Erdenet  
   
 16:00 – 17:00 Meeting with Dr Batgombo & Dr Tsen Sengelmaa, Poisoning 
Hospital, Ulaanbaatar 
   
Friday 29/09/06 09:00 – 10:00 Meeting with Dr Munkhdelger, Ministry of Health 
   
 11:00 – 12:45 Meeting with Dr. Ganchimeg, head, CSW NGO & Dr. Enkctuya, 
gynaecologist, Future for Adolescents & Reproductive Health NGO  
   
 14:00 – 14:30 Meeting with Gundalai Lamjov, Minister of Health 
   
 19:00 – 21:00 Focus group with Chinese construction workers 
   
Monday 02/10/06 09:00 – 10:00 Meeting with Dr Khun, Ministry of Health 
   
 10:00 – 12:00 Site visit to Narcology Hospital 
   
 13:00 – 15:00 Site visit to Homeless Persons‟ Hospital 
   
Tuesday 03/10/06 10:00 – 11:30 Meeting with Mr Dashtudev and Mr Bat-Amgalan, Ministry of 
Justice and Home Affairs 
   
Wednesday 04/10/06 10:00 – 13:00 Advisory Group Meeting 
   
 16:30 – 17:30 Meeting with Gundalai Lamjov, Minister of Health 
   
Friday 05/10/06 09:00 – 13:00 Advisory Group Meeting and training. 
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Appendix II:  Advisory Group, invited members  
(Organisations listed in alphabetical order) 
Organisation Representative 
Association Against Alcoholism and Drug Abuse Bayaraa D., President 
  
Association to Protect Population From Drug and Opium Sh. Lkhagvasuren, Head 
  
Centre of Mental Health and Narcology Prof. Erdenebayr Luvsandorj, General Director 
 
Dr Elena Kazantseva, Clinician 
 
Dr Davaasuren Oyunsuren, Clinician 
  
Criminal Police Department Nyamdorj Nyamtseveen, Police Major, Chief of Section 
 
Ms Chimedregzen 
  
Foundation Against HIV/AIDS and Drug Abuse Mr Jargalsaikhan, Head 
  
Institute of Public Health, Health Service University Dr Sumberzul 
  
Ministry of Health 
  
Gundalai Lamjav, Minister of Health 
 
A. Otgonbold, Vice Minister of Health 
 
Munkhdelger Chimedtseren, Head Pharmaceuticals and 
Medical Devices 
 
Dr Khun Tsevegmidiin, HIV/AIDS Department 
 
Dr Bayannas  Head of Ministry of Health Global 
Fund Supported Projects to fight HIV/AIDS & TB 
 
Dr Bavuu Enkhjin, HIV/AIDS/STI Officer, 
Ministry of Health Global Fund Supported Projects to 
fight HIV/AIDS & TB 
 
Chultemsuren Byambaa, HIV/AIDS/STI Officer, 
Ministry of Health Global Fund Supported Projects to 
fight HIV/AIDS & TB 
  
Ministry of Justice and Home Affairs Gongoriin Dashtudev, Chief Secretary 
  
 Bat-Amgalan Bazargochoo, Senior expert, Police Major 
  
National AIDS Foundation Altantsetseg Batsukh, Executive Director 
  
National Anti-drug Centre Azbayar L., Head 
  
 B Tumendemberel 
  
Railway Hospital, Ulaanbaatar Dr Enkhjargal 
The Together Centre Mendbayar, Social Worker 
  
United Nations Children‟s Fund Ider Dungerdorj, National Officer, HIV/AIDS 
  
United Nations Population Fund 
  
Delia Barcelona, UNFPA Representative 
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Organisation Representative 
Enkhjargal Khorloo, Technical Advisor 
STI/HIV/AIDS and LMIS 
  
World Health Organisation Mr Robert Hagan, WHO Representative in Mongolia 
 
Dr Salik Govind, Public Health Specialist 
 
Dr Narantuya, Communicable Diseases Surveillance 
and Response Project Officer 
 
Dr R. Jagalmaa Project Officer 
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Appendix III: Questionnaire, English Language Version 
 
 
 
 
RAR - Drug Use and HIV – Mongolia 
 
Questionnaire: IDU, DU 
Location  
Date  
Interviewer  
 
  59 
A. Demographic Information 
A1 How old are you? years old 
 
A2 SEX Male  1 
Female 2 
Other  3 
     
A3 What city or province do 
you live in? 
 
     
A4 What type of 
accommodation do you 
live in? 
Homeless 1 
Small house 2 
Apartment 3 
Large house 4 
Other 5 Specify: 
 
     
A5 What is your marital 
status? 
Never married 1 
De-facto relationship 2 
Married 3 
Divorced 4 
Widowed 5 
 
A6 What is your religion? None 1 
Buddhist 2 
Christian 3 
Muslim 4 
Other 5 Specify: 
  
 
A7 Can you read and write? Yes 1 
No 2 
 
A8 How many years of school have 
you completed? 
School years 
University  years 
 
A9 Do you have 
a job? 
Yes 1 Specify: 
No 2 
 
A10 How much do you earn in 
a day? 
Average: T 
Maximum: T 
Minimum: T 
 
A11 How much do you earn in a month on 
average? 
T 
 
  
 
A12 If you do not have an income how Family 1 
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do you support yourself? Spouse 2 
Friends 3 
Welfare 4 
NGO 5 
Theft 6 
Selling drugs 7 
Other 8 
 
 
 
B. Drug use history 
B1 How old were you when you first 
drank alcohol? 
0 Never 
 Years 
 
B2 How old were you when you first used any other 
drug (not including alcohol or tobacco)? 
0 Never 
 Years 
 
B3 What was this drug?  
 
B4 How did you take this drug 
when you first used it? 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
 
B5 What other ways have you 
taken this drug? 
(more than one answer possible) 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
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B6 Why did you start using this drug? 
 
 
 What other drugs have you ever used? (Show FLASH CARD to prompt): 
B7a Name of drug How old were you 
when you first used 
this drug? 
How have you taken this drug? 
(more than one answer possible) 
 
years of age 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
Have you used this drug in the last 3 
months? 
Yes 1 
No 2 
 
B7b Name of drug How old were you 
when you first used 
this drug? 
How have you taken this drug? 
(more than one answer possible) 
 
years of age 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
Have you used this drug in the last 3 
months? 
Yes 1 
No 2 
 
 
 
 
 
 
 
B7c Name of drug How old were you 
when you first used 
this drug? 
How have you taken this drug? 
(more than one answer possible) 
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years of age 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
Have you used this drug in the last 3 
months? 
Yes 1 
No 2 
 
B7d Name of drug How old were you 
when you first used 
this drug? 
How have you taken this drug? 
(more than one answer possible) 
 
years of age 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
Have you used this drug in the last 3 
months? 
Yes 1 
No 2 
 
B7e Name of drug How old were you 
when you first used 
this drug? 
How have you taken this drug? 
(more than one answer possible) 
 
years of age 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
Have you used this drug in the last 3 
months? 
Yes 1 
No 2 
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B8a What drug have you primarily used in 
the last month? 
 
B8b For how long have you used this drug 
regularly? 
Months:  
Years:  
B8c How many times do you use this drug 
in a day? 
Average:  
Maximum:  
Minimum:  
B8d How much of this drug do you use each 
day? 
Average:  
Maximum:  
Minimum:  
B8e How have you taken this drug in the 
last month? (more than one answer possible) 
Inject – intra-muscular 1 
Inject – intra-venous 2 
Swallow or Drink 3 
Smoke 4 
Keep under lips/tongue 5 
Sniff 6 
Other: 7 
 
 
B9a When was the last time you used a drug? days ago 
B9b What was this drug?  
 
B10 How much money do you spend on 
drugs each day? 
Average: T 
Maximum: T 
Minimum: T 
 
B11 Does anyone else in your 
family use drugs? 
No 1 
Yes 2 Who? Mother 1 
   Father 2 
   Sister 3 
   Brother 4 
   Husband or Wife 5 
   Son or Daughter 6 
   Other: 7 
    
   What Drug?:  
   
 
B12 How many of your friends 
use drugs? 
None of my friends 1 
A few of my friends 2 
Some of my friends 3 
Most of my friends 4 
All of my friends 5 
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B13 Where have you ever 
bought drugs from? 
Pharmacy – with a prescription 1 
Pharmacy – without a prescription  2 
Hospital 3 
Directly from a doctor or nurse (no script) 4 
From a drug dealer 5 
From friends 6 
From a bar 7 
Other 8 
 
 
B14 Where do you most often 
buy drugs from? 
Pharmacy – with a prescription 1 
Pharmacy – without a prescription  2 
Hospital 3 
Directly from a doctor or nurse (no script) 4 
From a drug dealer 5 
From friends 6 
From a bar 7 
Other 8 
 
 
B15 Has anyone you 
know used any of 
the following 
drugs IN 
Mongolia? 
Heroin 1 Describe: 
Cocaine 2 
Amphetamine type 
substances 
3 
Ecstasy 4 
Other 5 
 
B16 Do you want to stop using drugs No 1 
Yes 2 
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C Injecting Drug Use 
Complete this section if in Section B the participant reports having injected any drug at 
any time. 
 
C1 Have you ever injected a medicine at home to 
improve your health? 
Yes 1 
No 2 
 
C2 Have you ever injected a medicine or drug that has 
not been prescribed for you by a doctor? 
Yes 1 
No 2 
 
C3 When you inject any drug how often do you 
use a new clean needle and syringe? 
All of the time 1 C8 
Most of the time 2 
Some of the time 3 
Very rarely 4 
 
C4 When you inject any drug how often do you 
share the needle and syringe? 
Never 1 
Very rarely 2 
Some of the time 3 
All of the time 4 
 
C5 How many different people have you shared a needle and/or syringe 
with in the last 3 months? 
 
 
C6 If you do not use a new needle and syringe, 
how often do you clean the needle and 
syringe before using it? 
All of the time 1 
Some of the time 2 
Very rarely 3 
Never 4 C8 
 
C7 How do you clean the 
needle and syringe? 
With bleach 1 
By boiling 2 
With clean water 3 
With hot water 4 
With any water available 5 
Wiping with a cloth 6 
Other: 7 
 
C8 Where do you get new needles 
and syringes? (more than one answer 
possible) 
 
Pharmacy 1 
Hospital 2 
NGO 3 
Friends 4 
Other 5 
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C9 Do you ever mix up your drugs 
with water before injecting? 
Yes 1 
No 2  Section D 
 
C10 When mixing up drugs before injecting how 
often do you share the mixing up equipment 
(e.g. spoon or vial or cooker, filter, water 
vessel) 
All of the time 1 
Some of the time 3 
Very rarely 4 
Never 5 
 
 
D. Disease History 
D1 Since you began using 
drugs have you suffered 
from any of the following? 
Tuberculosis 1 
Jaundice  
(explain that this means eyes and urine turn yellow and remain so for 
approximately one month) 
2 
Weight loss 3 
Diarrhoea for more than a month 4 
Fever for more than one month 5 
Abscess 6 
Any other illness: 7 
 
 
D2 If yes to above what did you do 
for a cure? 
See doctor 1 
Treated yourself 2 
Did nothing 3 
Other: 
 
 
4 
 
 
A drug overdose is when a person takes too much of a drug and suffers a serious 
negative effect. When a person overdoses on morphine or another opiate they 
pass out and stop breathing.  
D3 Have you ever overdosed on 
morphine or another opiate? 
No 1 
Yes 2 How many times?  
      
D4 Have you ever overdosed on 
any other drug? 
No 1  D6 
Yes 2 What drug? 
 
 
D5 When you overdosed did you receive 
medical assistance or help from a friend 
No 1 
Yes 2 Specify: 
 
 
 
 
 
  
 
D6 Do you know what to do if 
somebody overdoses on 
No 1 
Yes 2 Describe: 
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morphine or another drug?  
 
 
 
 
 
D7 When you go and see a doctor 
or go to a hospital do you feel 
that you are treated differently 
because you are a drug user? 
No 1 
Yes 2 Describe: 
 
 
 
 
 
 
 
 
 
Section E. Sexual behaviour 
“The following questions are about sexual behaviour. This topic is often 
embarrassing and difficult to talk about.  
Everything you tell us will be kept confidential. You do not have to answer 
questions that you do not want.” 
 
E1 Have you ever 
had sex? 
No 1 
Yes 2 
How old were you when you first 
had sex? 
 
 
For married participants only: others E3 
E2 Have you ever had sex with anyone other 
than your husband or wife? 
No 1 
Yes 2 
 
E3 Have you ever had sex with a prostitute? No 1 
Yes 2 
 
E4 Have you ever had sex with somebody of the 
same sex as you? 
No 1 
Yes 2 
 
E5 How many sexual partners have you had in the last year?  
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E6 When you have sex how often do you use 
condoms? 
All of the time 1 
Some of the time 2 
Very rarely 3 
Never 4 
 
E7 If you have had sex with a prostitute: 
Did you use a condom? 
All of the time 1 
Some of the time 2 
Very rarely 3 
Never 4 
 
E8 When you have sex with your husband/wife 
or boyfriend/girlfriend how often do you use 
a condom? 
All of the time 1 
Some of the time 2 
Very rarely 3 
Never 4 
 
E9 If you have sex with people of the same sex 
how often do you use a condom? 
Never 1 
Very rarely 2 
Some of the time 3 
Most of the time 4 
 
 
Section F. HIV/AIDS 
F1 Have you ever heard of HIV/AIDS? No 1  Section G 
Yes 2 
 
F2 Do you know how 
HIV/AIDS is 
spread? 
No 1 
Yes 2 Describe how you believe HIV is spread: 
 
 
F3 Do you think you 
may get 
HIV/AIDS? 
No 1 
Yes 2 
Why do you think this: 
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F4 Have you ever been tested for HIV/AIDS? No 1  F7 
Yes 2 
 
F5 Do you know the result? No 1  F7 
Yes 2 
 
F6 What was the result? Positive 1 
Negative 2 
 
 
 
Section G. Existing Services 
 
G1 Have you ever tried to stop using drugs? No 1 
Yes 2 
 
G2 Have you ever received any help for your drug 
use? 
No 1  G5 
Yes 2 
 
G3 Have you ever received 
any help for your drug use 
from a health service, an 
NGO or any other place? 
No 1  G5 
Yes 2 From where? 
 
 
 
 
 
 
 
 
 
G4 Was it difficult to get help 
for your drug use 
No 1 
Yes 2 Describe why it was difficult:: 
 
 
 
 
 
 
 
 
 
  
F7 Do you know any other 
people who are HIV 
positive? 
No 1 
Yes 2 Are they drug 
users? 
No 1 
  Yes 2 
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G5 Can you name the places 
where you think you could 
go for treatment of drug 
problems? 
No 1 
Yes 2 List these services: 
 
 
 
 
 
 
 
 
 
G7 What kind of help do you think you would need to stop using drugs? 
 
 
 
 
 
 
 
G7 If you inject drugs what kind of help do you think you would need to stop 
injecting drugs? 
 
 
 
 
 
 
 
 
G8 Have you ever been in police lock up? No 1 G10 
Yes 2 
 
G9 Have you been in police lock up in the last 
year? 
No 1 
Yes 2 
 
G10 Have you ever been in prison? No 1 End 
Yes 2 
 
G11 Have you been in prison in the last year? No 1 
Yes 2 
 
G12 Was it possible to get drugs inside prison? No 1 
Yes 2 
 
END 
 
 
